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 The current study was designed to measure the effect of an eight week resistance training 
program on the body composition of persons with type II diabetes.  To assess the effectiveness of 
the program, body composition was measured before and immediately following the training 
period.  Forty-one subjects (female = 25, male = 16) participated in the study.  Seventeen were 
randomly assigned to the resistance training group and eighteen were assigned to the control 
group.  Resistance training was performed under supervision three days a week for eight weeks 
on eleven different exercises (triceps press, bicep curl, lat row, bench press, hip flexion, hip 
extension hip abduction, hip adduction, leg press, dorsiflexion, plantarflexion) with a progression 
up to loads representing 80% of one-repetition maximum. A two-way ANOVA with repeated 
measures was applied to evaluate the repeated factor of pre vs. post testing and the fixed factor 
comparing treatment (resistance training) vs. control group.  All statistical tests were evaluated at 
p ≤ 0.05 level of significance.   Strength was significantly improved in the training group across 
all eleven exercises over the eight week time period (p < 0.05).  The results of the ANOVA 
showed a significant decrease in body fat percentage (p = 0.003), a significant increase in lean 
body mass (p=0.011), and a significant decrease in fat mass (p = 0.017 for both groups and no 
significant difference between the two groups). Percent body fat decreased from 41.25 ± 10.24 
kg to 40.11 ± 9.98 kg in the treatment group and 40.78 ± 10.91 kg to 40.06 ± 10.82 kg in the 
control group.  Lean body mass increased from 53.11 ± 10.12 kg to 54.62 ± 11.97 in the 
treatment group and 53.11 ± 12.17 kg to 53.41 ± 12.50 kg in the control group.  Fat mass 
decreased from 39.02 ± 15.09 kg to 37.83 ± 14.69 kg in the treatment group and 39.11 ± 20.60 to 
38.32 ± 19.96 kg in the control group.    There was no significant interaction effect for any 
variable (p < 0.05) and no significant change in fat mass across tests or groups (p < 0.05).  These 
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results indicate that changes in body composition seen over an eight week time period could not 
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The Problem and Its Scope 
Introduction 
While there are numerous studies involving the body composition of persons with type 2 
diabetes (Goodpaster et al., 2000, Han et al., 1998 Svendson et al., 1997), studies examining 
body composition changes caused specifically by resistance training are fewer (Ibanez et al. , 
2005, Dunstan et al., 2005, Brooks et al., 2007) .  Persons with type 2 diabetes (T2D) tend to 
have a higher body mass index (BMI), larger waist circumference, higher waist-hip ratio, and 
higher percent body fat (Goodpaster et al., 2000, Han et al., 1998 Svendson et al., 1997).  While 
these characteristics can be modified through exercise in the general population, it is less 
understood how this can be safely accomplished in persons with T2D.  There is evidence to 
suggest that resistance training may be helpful in correcting lower body strength deficits, 
decreasing abdominal adiposity and decreasing intramuscular adiposity, although these kinds of 
studies involving persons with T2D are uncommon (Ibanez et al., 2005).   
Purpose of Study 
 The purpose of the study was to evaluate the effect of a resistance training intervention 
on body composition of persons with T2D.  More specifically, will an 8-week resistance training 
protocol increase lean body mass, decrease fat mass, and decrease percent body fat  when 
compared to a non-training group?  In normal populations and in some diabetic populations, 





There will be no significant difference in body composition of individuals with T2D between 
groups who participate in a strength training intervention and those who do not participate in 
training at all.  
Significance of Study 
 The significance of the study was to determine whether or not progressive resistance 
training will have an effect on the body composition subjects with T2D.  Currently there is little 
published research about body composition response to progressive resistance training.  Since 
adiposity and muscle loss are generally considered a marker of diabetic risk and insulin 
resistance, a positive result in this study may indicate the usefulness of resistance training in 
exercise prescription programs for persons with T2D. 
Limitations of Study 
1. Daily living or other physical activity was not be monitored.  This may or may not 
have a significant effect on body composition. 
2. Body density changes seen may be due in part to individual predisposition and not 
strictly the training intervention. 
3. Subjects’ diets during the period of the study were not accounted for and may 
unfavorably effect body composition with respect to fat mass changes or lack thereof. 
4. Subjects who do not attend all scheduled sessions and adhere to the resistance 
training protocol may compromise increases in strength and lean body mass 
compared to subjects who are compliant.    
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5. Life Measurement Inc. (Concord, CA), manufacturers of the BODPOD, report 
accuracy in subjects up to 165Kg.  Should subjects’ weight increase beyond this mark 
for any reason over the course of training, body composition data may not be valid. 
6. Although detailed instructions were given, air density plethysmography testing errors 
related to compliance in diet or clothing may create significant differences in 
estimated body density. 
7. The study interventions occurred during different seasons (winter and spring), and a 
seasonal effect on leisure time activity, which may affect body composition, is known 
to exist (Buchowski et al., 2009). 
 
Definition of Terms 
Aerobic Exercise- Any activity that uses large muscle groups, can be maintained continuously, 
and is rhythmic in nature (Kraemer et al., 2002).  
Air Displacement Plethysmography (ADP) – A method of determining body composition 
utilizing the inverse relationship between pressure and volume (Boyle’s law) to measure body 
volume directly (McCrory, Mole, Gomez, Dewey, Bernauer, 1998). 
Diabetes Mellitus - a chronic metabolic disorder in which utilization of carbohydrate is impaired 
and that of lipid and protein enhanced; it is caused by an absolute or relative deficiency of insulin 
and is characterized, in more severe cases, by chronic hyperglycemia, glycosuria, water and 
electrolyte loss, ketoacidosis, and coma; long-term complications include neuropathy, 
retinopathy, nephropathy, generalized degenerative changes in large and small blood vessels, and 
increased susceptibility to infection (Tortora, 2002).   
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Hydrodensitometry- The technique of measuring body composition in the water, where the body 
is buoyed with a weight equal to the counterforce of the water displaced.  A person with more fat 
free mass for the same total body weight will weigh more in the water, having a lower 
percentage of body fat (Whaley, Brubaker, Otto, 2006). 
Insulin Sensitivity- A state of diminished effectiveness of insulin in lowering the levels of blood 
sugar, usually resulting from insulin binding by antibodies, and associated with such conditions 
as obesity, ketoacidosis, and infection (Stedman, 2003). 
Insulin Resistance- diminished effectiveness of insulin in lowering plasma glucose levels, 
arbitrarily defined as a daily requirement of at least 200 units of insulin to prevent hyperglycemia 
or ketosis; usually due to binding of insulin or insulin receptor sites by antibodies; associated 
with obesity, ketoacidosis, and infection (Stedman, 2003).   
One Repetition Maximum (1RM) – The greatest amount of weight that can be lifted with the 
proper technique for only one repetition (Baechle & Earle, 2000). 
Progressive Resistance Training – A method of increasing the strength of weak or injured muscle 
by gradually increasing the resistance against which the muscle works (Mosby, 2009).  
Type 2 Diabetes – Type 2 diabetes is characterized by insulin resistance in peripheral tissues as 





Review of Literature 
Introduction 
 Body composition responses to strictly resistance training programs in persons with type 
2 diabetes (T2D) are not well documented in the available research.  Persons with T2D share a 
number of common body composition characteristics that appear in the literature such as 
abdominal adiposity, intramuscular adiposity, and decreased thigh muscle mass (Goodpaster et 
al., 2000, Han et al., 1999).  These characteristics may help identify insulin resistance, diabetic 
risk, and or diabetic disease.   Anthropometric measurements such as waist circumference and 
waist/hip ratio are becoming more recognized as valid predictors or indicators of diabetic disease 
than less definitive measures like BMI.  Relative composition of the thigh is also recognized as 
being closely associated with type 2 diabetic disease and or insulin resistance (Dube et al., 2006).  
Although there is not much data to support body composition changes due only to resistance 
training in this population, the research demonstrates that it may be helpful in increasing strength 
and helping to maintain bone mass in older persons with T2D (Daly et al, 2005). 
Body Composition Characteristics of Persons with Type 2 Diabetes 
A study by Goodpaster, Thaete, Simoneau and Kelley (1997) evaluated the relationship 
between abdominal fat, thigh muscle composition, and insulin sensitivity.  The sedentary 
subjects consisted of 26 healthy men and 28 healthy premenopausal women that were equally 
represented in lean (BMI <28 kg/m²) and obese (BMI >29kg/m²) categories.  Body composition 
was evaluated with dual x-ray absorptiometry for whole body fat mass and fat free mass.  
Computed tomography was used to measure cross-sectional subcutaneous and visceral 
abdominal adipose tissue as well as thigh muscle attenuation.  Insulin sensitivity was measured 
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with a euglycemic clamp procedure.  Insulin resistance showed a moderately higher correlation 
to subcutaneous fat than visceral in subjects (r = 0.61 versus 0.52). Increased thigh muscle 
density, measured by CT, was correlated positively with insulin sensitivity (r = 0.47).  
Goodpaster et al. (1997) mention that for this reason, thigh muscle attenuation was the best 
marker of insulin resistance among obese populations. 
Anjana, Sandeep, Deepa, Vimaleswaran and Farooq (2004) examined visceral abdominal 
fat, central abdominal fat, and anthropometry as related to T2D.  There were two groups of 82 
Asian-Indian subjects, one group consisted of persons with T2D while the other did not.  
Subcutaneous and visceral fat were measured with computed tomography.  Total body and 
abdominal fat were assessed using DEXA.  Subjects with T2D demonstrated significantly higher 
BMI (26.1 kg/m
2
 v. 24.0 kg/m
2
) and waist circumference than non-diabetic subjects (92.3 cm v. 
87.2 cm).  Central and visceral abdominal fat showed a strong association with each other in both 
subject groups (r = 0.691 non-diabetic, r = 0.520 diabetic).  BMI did not show an association 
with visceral fat in diabetic groups although it demonstrated correlation with central abdominal 
fat (visceral fat p > 0.05, central abdominal fat r = 0.788, 0.565 for non-diabetic and diabetic 
subjects respectively).  Significantly higher visceral and abdominal fat in the younger subjects 
with type 2 diabetes was seen compared to same aged participants without diabetes (Anjana et 
al., 2004). 
Azuma, Heilbronn, Albu, Smith, Ravussin, Kelley et al. (2007) examined adipose tissue 
distribution in relation to insulin resistance in subjects with T2D.  The subjects were 67 obese 
participants with type 2 diabetes, mean age 60, and 35 similarly obese non-diabetic subjects with 
a mean age of 55.  Fat mass, fat-free mass, leg fat mass, leg fat free mass and abdominal fat mass 
were evaluated with DEXA.  Computed tomography imaging was used to evaluate subcutaneous 
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adipose tissue and visceral adipose tissue in the thigh and the abdomen.  At similar total fat mass, 
there were several body composition differences found between type 2 diabetics and non-
diabetic populations.  Among these were greater trunk fat mass (18.7 kg v. 18.2 kg), significantly 
less leg fat mass (10.4 kg v. 11.7 kg), greater fat content in the liver (48 HU v. 55 HU), and 
greater subfascial thigh adipose tissue (20.5 cm
2
 v. 16.7 cm
2
).  With respect to insulin resistance, 
trunk fat mass, leg fat mass, and hepatic fat mass were all related to severity. 
Racette, Evans, Weiss, Hayberg and Holloszy (2006) investigated whether whole-body 
adiposity, abdominal adiposity, or cardiovascular fitness was the strongest predictor of insulin 
resistance in older adults among these.  Four hundred seven healthy male and female subjects 
aged 50-95 years participated in the study.  Participants were tested for maximal oxygen 
consumption (VO₂max), BMI, and waist circumference.  Subjects were evaluated for total body 
fat mass and fat-free mass using either hydrodensitometry or DEXA.  Subjects’ insulin 
sensitivity was calculated using fasting insulin and glucose, and oral glucose tolerance tests.   
Abdominal adiposity where estimated by waist circumference was shown to have the greatest 
influence on insulin resistance (r = 0.52 v. % fat r = 0.40), where greater circumference was 
related to greater insulin resistance.  Age did not show any effect on insulin sensitivity in the 
participants (r = 0.015).  Fitness did show a significant effect on these older participants’ insulin 
sensitivity  (r = 0.23); however, waist circumference showed a greater effect on insulin 
sensitivity (r = 0.52). 
A study by Meisinger, Doring, Thorand, Heier and Lowel et al. (2006) examined gender 
differences regarding the risk of type 2 diabetes in the general population.  The population 
consisted of 6012 non-diabetic subject ages 35-74.  Height, weight, waist circumference, and hip 
circumference were sampled and waist-hip ratio was calculated.  Follow up of diabetic status 
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was performed 8 years later and  high body mass index (Male: 126/789 subjects @ BMI ≥ 29.4 
kg/m
2
, Female: 94/747 subjects @ BMI ≥ 29.5 kg/m
2
), waist circumference (Male: 131/823 
subjects @ WC ≥ 102.0 cm, Female: 100/743 subjects @ WC ≥ 90.5 cm), and waist-hip ratio 
(Male: 116/777 subjects @ ≥ 0.97, Female: 89/752 subjects @ ≥ 0.85)  were all independently 
and strongly related in both sexes to incidence of T2D.  Male subjects demonstrated a higher 
incidence rate based on any of these three measures separately than did female subjects.  BMI, 
waist-hip ratio, and waist circumference showed an additive effect on T2D risk, specifically BMI 
and waist circumference or BMI and waist-hip ratio.  In females, those with a low BMI (≤ 29.4) 
and high waist circumference (≥ 90.5 cm) showed a higher risk (hazard ratio = ~3.0) where those 
with high BMI (>29.4 kg/m
2
) and low waist circumference (< 90.5 cm) had no significantly 
elevated risk (hazard ratio < 2.0) of developing type 2 diabetes (Meisinger et al., 2006). 
Han, Feskens, Lean and Seidell (1998) examined the association of anthropometric 
measures with type 2 diabetes.  Subjects consisted of 5887 men and 7018 women ages 20-59.  
These included weight, height, waist circumference, and BMI.  In this study, large waist 
circumference, high body mass index, and high waist to hip ratio were associated with type 2 
diabetes, insulin resistance, and hyperglycemia.  Shorter women (<162.5 cm) were found to be 
twice as likely and shorter men (< 174.8 cm) found to be five times more likely to have type 2 
diabetes compared to taller subjects (≥ 168.5 cm and ≥ 181.5 cm, respectively).   
Snijder, Dekker, Visser, Bouter, Stehouwer, Kostense et al. (2007) studied the 
associations of hip, thigh, and waist circumference to T2D prevalence.  Six hundred nineteen 
men and 738 women ages 50-75 participated in the study.  Fasting and postload glucose 
concentrations, BMI, waist and hip circumference, and thigh circumference were measured.  
Waist to hip ratio and waist to thigh ratio was also calculated.  The results indicated that hip and 
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thigh composition can be important measures of fitness with respect to type 2 diabetes and 
insulin resistance.  Ratios of body circumference showed much better prediction of future type 2 
diabetes than overall obesity evaluated by BMI (WHR v. BMI odds ratios, women: 2.15 v. 1.20 
men: 1.55 v. 1.79; WTR v. BMI odds ratios, women: 2.08 v. 1.31 men: 1.41 v. 0.97).  
Independent of age, BMI, sex, and waist circumference, larger hip or thigh circumference was 
associated with a lowered risk of type 2 diabetes.  However, waist circumference alone was 
associated with greater risk of type 2 diabetes. 
Goodpaster, Thaete and Kelley (2000) examined the relationship between thigh adipose 
tissue distribution and insulin resistance in obese persons with type 2 diabetes and in lean and 
obese glucose-tolerant subjects.  The subjects consisted of 3 groups, 15 lean glucose-tolerant 
participants, 40 obese glucose tolerant participants, and 11 obese participants with type 2 
diabetes.  They evaluated whole body fat mass and fat free mass with DEXA.  Thigh 
composition included intramuscular adipose tissue, subcutaneous adipose tissue, subfascial 
adipose tissue, and muscle density with computed tomography (CT).  Insulin resistance was 
measured using the hyperinsulinemic-euglycemic clamp method.  Goodpaster and associates 
(2000) found that adipose tissue accumulation between and around skeletal muscle is a strong 
predictor of insulin resistance (-0.45 mg*min/kg FFM) , where subcutaneous adipose tissue of 
the thigh is not (-0.36 mg*min/kg FFM).  Results showed that it was common for there to be 
much greater amount of subcutaneous adipose tissue in the thigh, and this was not necessarily 
associated with insulin resistance.  Increased low density muscle in obese subjects (attenuation 
values > 2SD below normal range) was correlated negatively with insulin sensitivity (r = -0.50).  
Those with greater intramuscular adipose deposits were shown to more closely match the profile 
of persons with T2D.   
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A study by Dube, Hoanisse, Prud’home, Lemieux, Bouchard, Perusse et al. (2006) 
compared muscle adiposity and fat distribution in subjects with type 1 and type 2 diabetes.  Of 
86 men and women, there were 18 otherwise healthy persons with type 2 diabetes, and 25 
persons with type 1 diabetes.  They measured height, weight, waist circumference, and 
calculated BMI.  Fat mass and fat free mass was evaluated using hydrodensitometry.  Computed 
tomography was used to evaluate total adipose tissue, visceral adipose tissue, subcutaneous 
adipose tissue, mid thigh muscle attenuation, and mid thigh bone.  Subjects with T2D showed 
greater cross-sectional areas of subcutaneous and total thigh fat (141.3 cm
2
 and 149.5 cm
2
) than 
did those with type 1 diabetes (84.4 cm
2
 and 92.6 cm
2
, respectively).  Deep thigh adipose tissue 
to total thigh adipose tissue ratio was significantly greater in subjects with type 1 diabetes than 
those with type 2 (0.10 v. 0.06).  Total area of normal muscle attenuation as compared to low 
attenuation was greater in subjects with type 1 diabetes than T2D (150.2 HU v. 23.8 HU and 
96.0 HU v. 31.5 HU).    Dube et al. (2006) demonstrated that visceral abdominal adiposity and 
thigh muscle adiposity was higher in subjects with type 2 diabetes (213 cm
2
 and 149.5 cm
2
)  than 
well-controlled type 1 subjects (57 cm
2
 and 92.6 cm
2
).  Subjects with T2D exhibited greater mid-
thigh total adipose tissue but similar levels of deep adipose tissue to those with type 1 diabetes, 
demonstrating a smaller deep thigh to total thigh adipose ratio (0.06 v. 0.10). 
Park, Goodpaster, Strotmeyer, Kuller, Broudeau and Kammerer et al. (2007) studied loss 
of strength and muscle quality in older adults with T2D.  One thousand eight hundred forty older 
adults aged 70-79 were tested for leg and arm strength and muscle mass for baseline 
measurement and then 3 years later.  Body composition was assessed with DEXA for upper and 
lower extremity lean mass.  Strength was assessed using an isokinetic dynamometer for knee 
strength and an isometric dynamometer for hand grip strength.  In three years, older adults lost 
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significant knee extensor strength (109.1 Nm to 98.6 Nm) although subjects with T2D lost 
strength approximately 50% faster than those without.  Grip strength remained similar between 
groups, but subjects with type 2 diabetes lost slightly more upper extremity mass (-0.08 kg v. -
0.06 kg).  A greater quantity of lean muscle mass was also lost in the legs of subjects with T2D 
than in those without.  Quality of muscle declined more rapidly in subjects with T2D than 
controls (-1.57 Nm/kg v. -1.22 Nm/kg).     
A study by Poynten, Markovic, Maclean, Furler, Freund, Chisholm et al. (2003) 
examined body composition and insulin sensitivity in normoglycemic and diabetic obese adults 
five years following weight loss.   The participants consisted of eight normoglycemic subjects 
and seven subjects with T2D, with a mean age of 54.5 at the time of the five year follow up.  The 
initial weight loss protocol was a 1000 calorie deficit compared to subjects’ normal diets, and 
physical activity was directed to remain normal.  Subjects were measured for height, weight, 
waist circumference, and hip circumference.  BMI and waist-hip ratio were then calculated.  
Whole body DEXA was used to evaluate body composition by fat mass, lean tissue mass, and 
bone mineral content.  Insulin sensitivity was evaluated using a eutlycaemic-hyperinsulinaemic 
clamp procedure.  Five years after a one-month calorie reduced diet, all subjects tested had 
regained weight to a level that was not significantly different compared to pre-diet.  Waist-hip 
ratio had also increased in both groups at the end of the 5 year period (diabetic: 0.95 versus 0.91, 
non-diabetic: 0.91 versus 0.87).  Although total weights were similar, total fat mass had 
increased (non-diabetic: 36.2, diabetic: 36.8 kg) where lean body mass had not recovered from 




Air Displacement Plethysmography 
Air density plethysmography is a popular technique that has proven to be a useful and 
non-invasive method of measuring body composition when compared to other body composition 
standards in the research.  The BOD POD™ (Life Measurement, Inc. Concord, CA) is a dual-
chambered air displacement plethysmography that determines body composition through 
measuring body volume and density (Ball, 2005).  By using pressure and volume, the subject’s 
body volume is calculated by the change between measurements when empty and subject 
occupied (Ball, 2005).  Body density is calculated by dividing body mass by body volume, and 
percent body fat can be calculated by equation of choice.  Ball (2005) calculated percent body fat 
using the Siri percent fat equation (Siri, 1961):  %Fat = [(4.95/Db) – 4.5] * 100 and examined the 
interdevice variability in percent body fat estimates using the BOD POD™.  Twenty-six males 
and 24 females of various ages and body weight participated in the study.  Prior to testing, 
subjects avoided eating, drinking, and exercising for four hours to avoid inaccurate readings that 
can be caused by these.  Body volume, density, and percent body fat in participants was 
measured twice, and a third time if necessary.  These tests were conducted with two identical 
units in the same room under the exact same environmental conditions, all within 5 minutes of 
each other.  Ball (2005) demonstrated strong inter-device reliability (r > 0.98) of two BOD 
POD™s within the same lab.  There was no significant difference shown between percent body 
fat estimates, or test to test reliability.     
A study by Maddalozzo, Cardinal, and  Snow (2002) examined the concurrent validity of 
the BOD POD™ and dual energy x-ray absorptiometry.  Forty-three female college students 
participated in the study: 19 normally active, 10 volleyball team members, and 14 gymnastics 
team members.  Participants were instructed not to eat or exercise 3-4 hours prior to testing.  
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Subjects were tested on the same day with the BOD POD™ and dual energy x-ray 
absorptiometry (DEXA) to determine percent body fat.  DEXA and BOD POD™ were shown to 
be concurrently valid tools for determining percent fat in young females (23.8% v. 24.3%).   
 Anderson (2007) conducted a study regarding the reliability of air displacement 
plethysmography using the BOD POD™.  The subjects were 24 healthy adults, with varied self-
reported activity levels.  Subjects were tested on three separate days during a 3-7 day period for a 
body composition estimate according to manufacturer’s instructions.  Subjects were instructed 
not to eat or exercise for 3-4 hours prior to testing, although minimal water intake was allowed.  
Within-day reliability of body density and body fat measurements was high (0.97 – 0.98), but 
significant differences existed between days for percent body fat measurements.  Anderson cites 
the need for further practice of lung volume measurement testing procedure as the factor that 
could possibly help to decrease BF measurement variability between days. 
Fields, Hunter and Goran (2000) examined the effect of clothing on the validity of the 
BOD POD™ with hydrodensitometry.  Sixty-seven female participants of varied body 
compositions (6.5-51%), ages 18-55 years participated in the study.  Subjects were instructed not 
to eat 4 hours prior to their evaluations, and all hydrostatic weighing took place prior to air 
density plethysmography (ADP) to avoid body temperature fluctuations.  Subjects were 
evaluated with hydrodensitometry and ADP for four conditions: one group wore one-piece 
swimsuits, one group wore two-piece swimsuits, one group wore hospital gowns, and the other 
wore hospital gowns after the BOD POD™ was calibrated with a hospital gown in the chamber.  
A high level of agreement in body density was shown between underwater weighing and BOD 
POD™ measurements in subjects wearing one-piece and two-piece swimsuits, a 1.9% difference 
between methods (Db = 1.044 ± 0.014 vs. 1.040 ± 0.014 for both garments).  Subjects’ 
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measurements while wearing hospital gowns, whether the BODPOD™ was calibrated with the 
garment inside or not, did not show agreement with hydrodensitometry (Fields et al., 2000).           
  A study by Collins, Saunders, McCarthy, Williams and Fuller (2004) examined within 
and between laboratory precision of the BOD POD™ in body composition assessment.  The 
subjects consisted of 16 females and 14 males, additionally one male and one female subject 
participated in 10 repeat measurements in each BOD POD™ instrument.  Subjects were asked 
not to eat 2 hours prior to testing and all subjects refrained from eating or drinking during the 
testing period.  Subjects were measured at two separate laboratories with separate halves of the 
population taking initial measurements in opposite labs.  Collins et al. (2004) evaluated body 
density, percent body fat, fat mass, and fat-free mass for each subject in both laboratories.  
Significant bias (up to 0.29 l) was shown in body volume between labs in the 2 subjects that 
participated in the 10 consecutive tests.  There was not significant bias with the 30 subjects 
evaluated with the single tests (0.05 l).  Strong precision was seen within labs but varied between 
labs slightly due to varying environmental conditions within the laboratory. Collins et al. cite 
avoiding sudden pressure fluctuations, controlling constant temperature, and controlling airflow 
as methods of maintaining stable environmental conditions with respect to the BODPOD™.   
Resistance Training Considerations in T2D Population   
Daly, Dunstan, Owen, Jolley, Shaw and Zimmet (2005) evaluated the effect of high-
intensity resistance training on bone and lean muscle mass maintenance during moderate weight 
loss (0.25 kg/wk) in older adults with T2D.  Thirty-six subjects ages 60-80 participated in the 
study, all were sedentary, in the overweight BMI category (>27 kg/m² and <40 kg/m²), and had 
been diagnosed with T2D for at least six months.  Subjects participated in a six month 
intervention of three non-consecutive days per week supervised resistance training.    Subjects 
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completed three sets of 8-10 repetitions of nine exercises with free weights and a multi-station 
weight machines at 75-85% of their 1RM.  Subjects were evaluated at total body, femoral neck, 
and lumbar spine for bone mineral content, bone mineral density, lean body mass, fat mass, and 
percent body fat using DEXA.  Six months of supervised high intensity progressive resistance 
training protocol allowed subjects to maintain bone mineral content (1.192 g/cm
2
) and bone 
mineral density (2815 g) over the course of the weight loss.  This protocol also increased lean 
muscle mass and increased strength in upper and lower body by 43% and 33% respectively. 
 Kwon, Han, Ku, Ahn, Koo, Kim et al. (2010) examined the effects of resistance training 
on muscle and body fat mass and muscle strength in women with T2D.  Twenty-eight subjects 
with BMI > 23 kg/m
2
, ages 45-65 years participated in a resistance band exercise program for 12 
weeks.  The resistance training group demonstrated significant increases in upper body, trunk, 
and total muscle mass (3%), although no significant change in lower body muscle mass.  Total 
fat mass, subcutaneous fat, and abdominal fat decreased significantly in the training group (7.8, 
6.0, 6.5% respectively).  The control group decreased only subcutaneous fat significantly by 
2.6%.  While the control group strength actually decreased, subjects who trained made 
significant strength increases in upper (2.0 ± 4.3 kg) and lower body strength (10 ± 15.7 kg).   
A study by Ibanez et al. (2005) evaluated the effects of a twice a week progressive 
resistance training program on abdominal fat in persons with T2D.  The population of the study 
consisted of 9 older males age 66.6 +/- 3.1 with T2D.  Subjects participated in a 16 week 
intervention of bi-weekly supervised progressive resistance training program at 50-80% 1RM.  
Protocol for the first 8 weeks was 3-4 sets of 10-15 repetitions at 50-70% 1RM and protocol for 
the final 8 weeks was 3-5 sets of 6 repetitions at 70-80% 1RM.  Before and after the of 16 weeks, 
Ibanez et al. (2005) performed 7-site skinfold measurements, computed tomography (CT) 
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evaluation of visceral and subcutaneous adipose tissue, half-squat 1RM strength evaluation, and 
bench press 1RM strength evaluation.   Subjects increased leg strength by 17.1% and arm 
strength by 18.2%.  Intra-abdominal adipose tissue decreased by 10.3% and subcutaneous 
abdominal tissue decreased by 11.2%.  
A study by Brooks, Layne, Gordon, Roubenoff, Nelson, and Castaneda-Sceppa (2007) 
investigated the effects of strength training on muscle quality in persons with T2D.  Subjects 
were 62 hispanic adults at least age 55.  Baseline, mid-study, and final one-repetition maximum 
(1RM) values were tested for subjects.  Regional and whole-body fat mass and lean mass were 
evaluated with DEXA.  Muscle quality was quantified by units of weight lifted divided by units 
of muscle mass in kgs.  Half of the subjects participated in a 16 week resistance training protocol 
approximately 35 minutes in length using 5 pneumatic machine exercises.  During weeks 1-8, 3 
sets of 8 repetitions were performed at 60-80% of baseline 1RM.  During weeks 10-14, same 
protocol was followed except at 70-80% of mid-study 1RM.  Final 1RM was evaluated 
following the training protocol.  Subjects’ muscle quality was calculated by dividing leg press 
1RM by lean body mass of the leg.  The training group muscle quality improved significantly 
from 61 ± 5 to 100 ± 6 units and the control group decreased from 51 ± 4 to 48 ± 4 units. 
Herriott, Colberg, Parson, Nunnold and Vinik (2004) investigated the effects of 8 weeks 
of resistance training in older subjects with T2D.  The study consisted of 9 subjects with type 2 
diabetes, and 10 sedentary control subjects with a mean age of 50.6 and 54 respectively.  Eight 
weeks of 3x/wk resistance training, progressing from 50-70% 1RM demonstrated average 
strength increases of 36% and 41 % for upper and lower body respectively.  Subjects with or 




Type 2 Diabetes and Metabolic Considerations of Resistance Training  
 Castaneda et al. (2002) also demonstrated improved glycemic control in a 16-week 
progressive resistance training study of T2D subjects.  Training group subjects improved 
glycosylated hemoglobin levels (-12.6 ± 2 vs. +1.2 ± 1%), muscle glycogen stores (+31 ± 7 vs. -
23 ± 6%), and reduced their diabetes medication 72% compared to controls. 
 Castaneda, Layne, and Castaneda (2006) examined the effects of resistance training on 
sodium-dependent glucose co-transporter system (hSGLT3) and GLUT4 in older adults with 
T2D.  Eighteen older adults (65 ± 8 years) participated in the study (13 training, 5 control), with 
BMI of 32.1 ± 6.8 and 33.4 ±6.3 respectively.  hSGLT3 but not GLUT4 mRNA expression was 
significantly increased in skeletal muscle of training group (median relative expression ratios: 
hSGLT3 = 10 vs. 1, GLUT4 = 4 vs 1).  Muscle glycogen increased significantly in training 
subjects compared to controls (+44% vs. -13%).  Training group participants gained an average 
of 43 ± 29% whole body strength compared to 19 ± 31% seen in the control group. 
 Dunstan, Daly, Owen, Jolley, Courten, Shaw et al. (2002) examined the effects of high 
resistance training and dietary weight loss on glycemic control in older adults with T2D.  Both 
groups participated in a supervised dietary weight loss intervention, but one participated in 
resistance training for 6 months.  HbA1c  decreased significantly more in the resistance training 
group than the control group (1.2 ± 1.0 vs. 0.4 ± 0.8%).  Despite caloric restriction, lean body 
mass increased in the training group but decreased in the control group (0.5 kg ± 1.1 kg vs. -0.4 
± 1.0).  
Cauza, Strehblow, Metz-Schimmerf, Strasser, Hanusch-Enserer, Kostner et al. (2009) evaluated 
changes in muscle mass in persons with T2D during a 16-week resistance training program.  
Twelve men mean age 56.1 ± 0.9 years, and 8 women mean age 56.8 ± 1.0 years were recruited 
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to participate in a resistance training program for 16 weeks.  Fat mass decreased significantly at 
four months (pre: 39.6 ± 1.4 kg, post: 35.8 ± 1.7 kg) and lean body mass increased significantly 
(pre: 49.4 ± 1.8, post: 52.6 ± 1.7).  Subjects increased strength significantly for upper and lower 
body tests (upper: 67.4 ± 4.0 vs. 52.3 ± 3.1 kg, lower: 167.9 ± 9.7 vs. 113.6 ± 7.8 kg).  HbA1C 
also decreased significantly after 4 months of training (8.3 ± 1.7 vs 7.1 ± 0.2%). 
Behavioral Compensation and Energy Expenditure 
 Manthou, Gill, Wright, and Malkova (2010) investigated the relationship between weight 
loss responders and non-responders in a 12-week exercise program for overweight women.  
Thirty-four sedentary and obese or overweight women (BMI 29.3) mean age 31.7 years 
participated in an 8 week moderate-intensity (72-77% max HR) cardiovascular exercise program 
lasting 150 minutes per week.  Seven day physical activity diaries were kept by participants and 
heart rate monitors worn during waking hours to track activity levels. Subjects who experienced 
predicted body fat loss of 8 kg (± 2 kg) or greater were characterized as ‘responders’, while those 
who did not were characterized as ‘non-responders’.  While there was no significant difference 
in sedentary or sleeping energy expenditure nor energy consumption between these two groups, 
daily activity energy expenditure varied significantly (non-responders = -0.62 ± 0.39 MJ, 
responders = +0.79 ± 0.5 MJ).  This study demonstrated that overweight females who did not 
achieve weight loss during the exercise intervention had compensated by decreasing their daily 
physical activity energy expenditure. 
 McLauglin, Nalkova and Nimmo (2006) evaluated changes in spontaneous activity 
energy expenditure in 8 lean males and 8 lean females (mean BF = 17.5 ± 4.5%) undergoing an 
8-day exercise program that trained every second day.  Individuals were monitored for 8 days 
prior to the training period and during the training period itself.  Spontaneous activity energy 
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expenditure did not change significantly in males or females during the training period or the 
initial monitoring period.  Body mass only decreased in females significantly (pre: 63.3 ± 2.8 vs. 
post: 62.4 ± 2.7 kg).  Due to the lack of difference in spontaneous activity, McLaughlin et al. 
cites differences in energy intake response to training between genders.   
 Although the exact mechanism was undefined, Church, Martin, Thompson, Earnest, 
Mikus, and Blair (2009) examined the level of energy expenditure necessary to elicit a 
compensatory response in sedentary postmenopausal women (BMI: 25.0 – 43.0 kg/m
2
).  Four-
hundred eleven women were randomly assigned to a non-exercise control group or a training 
group at 4, 8, or 12 kcal/kg/week calculated energy expenditure for 6 months.  The amount of 
actual weight loss was compared to the amount of estimated weight loss to determine if some 
kind of compensation was present.  In the 4 and 8 kcal/kg/week groups, weight loss closely 
matched the predicted values and was considered to be without compensation (-1.0 kg and -2.0 
kg, respectively).  The 12 kcal/kg/wk group only demonstrated roughly half of the predicted 
weight loss (-1.5 kg vs. -2.7 kg).    
 Stubbs, Sepp, Hughes, Johnstone, King, Horgan et al. (2002) examined the relationship 
between varying amount of exercise energy expenditure and energy intake in a 7 day 
cardiovascular exercise protocol.  Six women (mean age 23.0 ± 0.6, BMI: 24.1 ± 1.0 kg/m
2
) 
were studied for 2 days during a sedentary routine, then measured during 7 days of exercise.  
Participants were assigned to a non-exercise group (0 MJ/day), a moderate exercise group (~1.9 
MJ/day), and a high exercise level group (~3.4 MJ/day).  While energy intake did not increase to 
match the values of energy expenditure, there was a decrease in energy expenditure of 0.3 
MJ/day of treatment.  Stubbs et al. hypothesize that the short duration did not allow time for 
adequate compensation in energy intake, and that fatigue was a primary factor in decreased 
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energy expenditure outside of training.  Where energy expenditure means totaled 9.2, 11.0, and 
12.1 MJ/day for non-exercise, moderate exercise, and high exercise groups; energy intake means 
were significantly lower at 8.9, 9.2, and 10.0 MJ/day. 
 King, Hopkins, Caudwell, Stubbs, and Blundell (2008) evaluated compensatory 
responses to exercise-induced energy expenditure.  Thirty-five overweight and obese sedentary 
men and women (mean age = 39.6 ± 11.0, mean BMI = 31.8 ± 4.1 kg/m2) participated in a 12-
week cardiovascular exercise program 5 days/wk.  The programs were individually designed to 
expend 500 kcal per session.  Energy intake was assessed over the course of the study as well. 
There was large variability in weight and fat changes among participants (-14.7 to 1.7 kg and -
9.5 to 2.6 kg).  Participants were then grouped into two groups: compensators and non-
compensators based on their energy intake.  Non-compensators decreased their mean energy 
intake -130.0 ± 485 kcal/day, and compensators increased their energy intake by 268.2 ± 455 
kcal/day.  King et al. cite the individual differences in hunger and energy intake response as the 
main compensatory mechanism for exercise-induced energy expenditure. 
Seasonal Effect on Daily Physical Activity Levels 
Buchowski, Choi, Majchrzak, Acra, Mathews and Chen (2009) evaluated seasonal 
physical activity changes in 63 women, ages 18- 55, of the southeastern United States.  Physical 
activity was measured by accelerometer during waking hours.  Physical activity was lower 
during the winter (131 ± 45 vs. 144 ± x 10
3
 counts/day) than the summer.  This effect was 
amplified on the weekends by 22,652 PA counts.   
Hamilton, Clemes, and Griffiths (2008) observed seasonal step count changes in adults 
from the UK in 96 adults (mean age = 41.0 ± 12.3, BMI 26.1 ± 5.1 kg/m
2
).  Daily mean step 
counts were significantly higher during the summer than the winter (10417 ± 3005 vs. 9132 ± 
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2841 steps/day).  One day-of-the-week effect was observed, that Sunday step count was 
significantly lower than Monday through Saturday by about 1500 ( ex: 10402 vs. 9246: summer 
9233 vs. 7714: winter, on Thursday and Sunday respectively).   
Matthews, Freedson, Hebert, Stanek, Merriam, Rosal (2001) studied 280 women and 300 
men from Massachusetts to observe seasonal changes in physical activity (mean age = 47.1 and 
48.2 years, BMI = 26.8 and 27.9 kg/m
2
).  Energy expenditure was estimated using by MET 
values of a given activity.  Daily physical activity (MET-hours/day) was calculated using the 
reported amount of time (hours/day) spent in each activity of a given MET intensity.  Activity 
totals increased during the summer in women and men by 1.0 and 1.4 MET-hours/day compared 
to winter.  Moderate intensity non-occupational activity increased by 2.4 and 2.0 MET-hours/day 
in females and males respectively.         
Summary 
 Increased abdominal adiposity, increased intramuscular adiposity, and diminished thigh 
muscle mass were all body composition characteristics demonstrated in persons with T2D 
(Goodpaster et al., 2000, Dube et al., 2006).  These are also related to insulin resistance, and or 
risk for diabetic disease.  While high BMI was associated with T2D, other anthropometric body 
composition measurements such as high waist hip ratio and high waist circumference more 
accurately predict diabetic risk.  Insulin resistance and T2D was also related strongly to thigh 
composition, where decreased muscular strength and increased intramuscular adipose tissue was 
seen in persons with existing disease.  Body composition values obtained from the general 
population with the BOD POD™ were in agreement with DEXA and hydrodensitometry.    
Resistance training was a safe and effective way to increase strength and decrease adipose tissue 
in limited populations with type 2 diabetes.  Resistance training has also been shown to have 
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positive physiological benefits to this population including improved glycemic control and 
decreased need for diabetes medication.  There are barriers to weight loss with respect to 
decreasing fat mass in the literature, such as compensatory decrease in physical activity of 
training group participants and compensatory increase in energy intake.  Time of year depending 
on location has also shown to be a factor that decreases daily physical activity during fall and 
winter months.  To examine the potential benefits of resistance training in T2D population, we 
measured the strength, body composition, and relevant anthropometric changes during an eight 
week resistance training program on this population.   
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Chapter III  
Methods and Procedures 
Introduction 
 Since body composition in persons with T2D tends to be related to increased adiposity 
and decreased lean muscle mass, a resistance and/or aerobic training protocol may be effective in 
helping to correct these issues.  The research shows that abdominal adiposity can be decreased 
by resistance training and that intramuscular adipose tissue can be decreased while strength is 
increased.  Additionally, insulin resistance appears to be related to decreased lower extremity 
strength and research demonstrates similar improvements in strength to non-diabetic persons, 
thus resistance training interventions are a safe and valid tool for improving and maintaining 
strength in persons with T2D.  Strength and aerobic training protocols have demonstrated 
effectiveness in promoting lean muscle mass and decreasing adipose mass in persons with T2D.  
Resistance training interventions can be a helpful part of exercise treatment for persons with T2D 
and determining whether an eight week program is of sufficient length to produce positive body 
composition results should be examined. 
 Description of Study Population 
 The study population consisted of 13 male and 22 female participants ages 37-84.  
Training status varied among participants and was reported by questionnaire.  Height and body 
composition varied among subjects and was not controlled for. All subjects involved were 
previously diagnosed with T2D. 
Design of Study 
The study design was a repeated measures treatment and control group design with two 
groups, both previously diagnosed with T2D.  The control group participated in no training, and 
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was pre and post tested over the same eight week time period as the training group.  The 
treatment group participated in an 8-week resistance training intervention.  At two separate dates 
corresponding to the beginning of the study and after eight weeks of training, percent body fat 
was measured with the BODPOD™  for each group and body composition determined. 
Data Collection Procedures 
Instrumentation.  Total body volume and body density were evaluated with the BOD 
POD™  (Body composition System; Life Measurement Instruments, Concord, CA).  Resistance 
training was performed with Cybex cable weight machines (Cybex International, Medway, MA). 
Measurement techniques and procedures.  Subjects were asked to refrain from eating 4 h 
prior to testing and to bring a swimsuit or tight fitting garment to the test. Upon arrival to the 
body composition lab the risks and benefits of participating in the study were explained.  Written 
informed consent and medical clearance was obtained from each subject and the procedures 
utilized were approved by the Human Subjects Review Committee at Western Washington 
University.  A copy of the informed consent document can be found in appendix A.  The medical 
clearance form can be found in appendix B.  Before the tests began, subjects were asked to void 
their bladder and height was measured to the nearest centimeter and weight to the nearest 0.1 kg.  
Waist circumference was measured at the navel to the nearest 0.5 cm, hip circumference was 
measured at the maximum circumference of the buttocks to the nearest 0.5 cm, and WHR was 
calculated by dividing the circumference of the waist by the circumference of the hips. BMI was 
calculated by dividing weight (kg) by height (m) squared. 
At each test session, procedures were fully explained to the subject, subjects put on tight-
fitting clothing, a nose-clip and swim-cap. Calibration was conducted prior to each subject’s 
entry into the BOD POD™ by placing the three liter reference volume cylinder in the chamber 
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and running the calibration function.  The ratio of the pressure amplitudes (reference chamber 
and testing chamber) for an empty chamber and the known three liter reference volume cylinder 
was then determined.  The BOD POD™ software calculates a regression equation between the 
testing chamber volume and the ratio of the pressure amplitudes.  The subject then entered the 
BOD POD™ for two trials of approximately 45 s each. During this stage, the subject's raw body 
volume (Vbraw) was determined with the testing chamber door being opened between trials. If 
both volumes were within 150 ml then the two trials were averaged. However, if the trials were 
not within 150 ml a third trial was performed and the two trials that were the closest were 
averaged.  
Data processing. The body density from the BOD POD™ was calculated as follows:  Db  
=M/(Vbraw.0.40VTG7SAA), where SAA = surface area artifact, VTG = thoracic gas volume, 
Vbraw = raw body volume, and M = subject mass.  Percent body fat was calculated as follows 
using Siri’s equation (1966): %Fat = [(4.95/Db) – 4.5] * 100.   
Training Procedures.  The 8-week resistance training protocol was as follows: following 
warm-up, each subject performed twelve exercises on weight machines.  In the first week of the 
training program, subjects were instructed on proper lifting technique for each exercise.  They 
performed 20-30 repetitions of each exercise using a low amount of resistance (10-30 pounds).  
During this time period, the experimenter predicted a one repetition maximum (1RM) for 
subjects on each exercise.  Subjects first selected a weight where they can perform 8-20 
successive repetitions.  Subsequently, the experimenter predicted 1RM using an equation 
developed by Bryzycki (1993): weight lifted/1.0278-(0.0278*number of repetitions).  This 
method of 1RM prediction was used to determine the weight subjects lifted for the remainder of 
that training period.  Reassessment of 1RM occurred every two weeks and lifting weight was 
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adjusted accordingly.  In the second week of training, weight lifted was 50% 1RM determined 
from the previous week.  Weight lifted increased to 80% 1RM in weeks three through eight.  
During this time period 3 sets of 8 repetitions were performed.  Subjects were allowed to 
complete training exercises in any order with each set being followed by a rest period.   
 All exercises were performed on Cybex™ cable weight machines.  The exercises 
included chest press, triceps press, leg extension or press, arm curl, row/rear deltoid, shoulder 
press, lat pull down, hip flexion, hip extension, hip abduction, hip adduction, plantar flexion, and 
dorsiflexion of the ankle.  If participants were unable to move the minimum amount of weight on 
the machine (5 pounds), they began by just pushing against the machine isometrically and 
working up to moving the bar.  Participants were instructed individually on each exercise and 
records were maintained for each session. 
Statistical Analysis  
To evaluate whether the training intervention was effective in changing the body 
composition of the subjects, a two way ANOVA with repeated measures was applied.  The 
design evaluated the time factor and the fixed factor compared groups.  Effect size cutoff values 
were set at r = 0.10, r = 0.30, and r = 0.50 for small, medium, and large respectively (Field, 
2005).   All statistical measures were evaluated at p < 0.05 level of significance.  Data analysis 




Results and Discussion 
Introduction 
 The purpose of this study was to examine the effects of a progressive resistance training 
exercise on the body composition of persons with type 2 diabetes.  The exercise program was 
eight weeks in duration with participants training three days per week.  Subjects in the control 
and treatment groups, both with T2D, were tested for body composition measures before and 
after eight weeks.  The training group exercises were on weight machines and included both 
upper and lower body exercises.  
Characteristics of the Subjects 
Subject characteristics for the control and training groups are presented in Table 1.   
Although 41 subjects had enrolled and undergone preliminary testing, due to attrition only 35 
completed the study.  The most common reason for not completing the program was that the 
subject never attended training after their preliminary testing.  This study was part of a large 
combined T2D study, and the long days of testing were not favored by some.  The possibility 
exists that this experience alone may have, for whatever reason, deterred them from beginning 






Table 1:  Subject Characteristics     
                
                
      Treatment   Control   
        
   Pre Post  Pre Post 
Age (yrs)        
  (X) 59.6 60.9  62.4 62.4 
  (SD) 10.7 22.5  10.9 10.9 
Weight (kg)        
  (X) 92.99 93.19  94.39 93.89 
  (SD) 25.88 26.39  18.49 19.16 
Height (cm)        
  (X) 167.19 165.83  166.67 166.42 




(cm)      
  (X) 113.92 109.47  108.91 105.71 





(cm)       
  (X) 118.36 113.31  115.97 111.35 




       
  (X) 0.97 0.96  0.95 0.96 




(kg/m2)        
  (X) 33.21 33.74  33.94 33.84 
  (SD) 8.62 8.57  6.12 6.29 
                
a
 Significant pre to post difference (p < 0.05) 
Thirty-five subjects participated in the study, 19 females and 16 males.  Seventeen were 
assigned to the resistance trained group, 12 females and 6 males. Eighteen were assigned to the 
control group, 10 females and 7 males. There was no significant change in weight between pre 
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and post tests.  Significant changes between pre and post tests existed for waist circumference 
(p=0.002), hip circumference (p=0.000), BMI (p=0.000), and waist-hip ratio (p=0.000) in the 
subjects.    There were no significant differences between the two groups.  The mean BMI of the 
subjects placed them all in the obese category (BMI of 30 or greater), according to the National 
Institutes of Health (http://www.nhlbisupport.com/bmi/).  Subjects’ mean initial waist 
circumference (113.92 cm treatment, 108.91 cm control) was also well above the recommended 
cutoff for type 2 diabetes risk established by the NHLBI of 88.9cm for men and 101.6 for 
women (http://www.nhlbi.nih.gov/health/public/heart/obesity/lose_wt/risk.htm).   
Weight 
The change in weight between pre and post tests was not significant (F1,33=0.121, p=0.731, 

2
p=0.004).  There was no significant effect between the groups (F1,33=0.022, p=0.882, 

2
p=0.001), and no interaction effect (F1,33=0.472, p=0.497, 
2
p=0.014).   
Waist Circumference 
The change in waist circumference between pre and post tests was significant (F1,33=11.021, 
p=0.002, 
2
p=0.250). There was no significant group difference in waist circumference 
(F1,33=0.464, p=0.501, 
2




The change in hip circumference between pre and post tests was significant (F1,33=48.425, 
p=0.000, 
2
p=0.595). There was no significant group difference in hip (F1,33=0.083, p=0.775, 

2







The change in BMI between pre and post tests was significant (F1,33=191.539, p=0.000, 

2
p=0.853) however,  there was no significant group (F1,33=0.083, p=0.775, 
2
p=0.003), and no 




The change in waist-hip ratio between pre and post tests was significant (F1,33=549.284, p=0.000, 

2
p=0.943). There was no significant group difference (F1,33=0.801, p=0.377, 
2
p=0.024), and no 
interaction effect (F1,33=0.000, p=0.983, 
2
p=0.000). 
The mean, standard deviation, and percent change of resistance training exercises are listed in 
table 2 for the training group. The control group was not tested.  There were significant increases 




Table 2: Absolute Strength Results of Resistance 
Training Program   
              
              
   Predicted 1-RM (kg)  
Exercise  Pre  Post  
% 
Change 
  X (SD)  X (SD)   




(kg)  31.1 (17.2) 58.2  (25.4) 87 




(kg)  16.5 (10.6) 25.6 (13.9) 54 





 33.1 (16.8) 53.7 (23.4) 62 






 27.1 (12.8) 42.7 (15.3) 57 
       
Bench Press
a
 (kg)  23.0 (10.4) 34.2 (14.8) 50 
       
Hip Flexion
a
 (kg)  28.8 (16.2) 59.1 (25.5) 104 
       
Hip Extension
a
 (kg)  32.3 (19.6) 70.3 (47.9) 118 
       
Hip Abduction
a
 (kg)  25.8 (15.1) 53.6 (22.2) 107 
       
Hip Adduction
a
 (kg)  28.6 (18.4) 58.9 (30.2) 106 
       
Plantarflexion
a
 (kg)  13.1 (4.9) 27.6 (16.2) 119 
              
       
a 
Significant pre to post difference (p < 0.05) 
 
The mean and standard deviation of body composition variables are listed by group for pre and 




Table 3:  Body Composition Characteristics    
                
                
      Treatment   Control   
        




       
  (X) 41.25 40.11  40.78 40.06 




       
  (X) 53.11 54.62  53.11 53.41 
  (SD) 10.12 11.97  12.17 12.50 
Fat Mass 
(kg)        
  (X) 39.02 37.83  39.11 38.32 
  (SD) 15.09 14.69  20.60 19.96 




 Significant pre to post difference (p < 0.05) 
Body fat percentage 
The decrease in body fat percentage between pre and post tests was significant (F1,33=10.498, 
p=0.003, 
2
p=0.241).  There was no significant difference between the treatment and control 
group (F1,33=.005,  p=0.942, 
2
p=0.000) and no significant interaction effect (F1,33=0.526, 
p=0.473, 
2





Figure 1. Mean Body Fat Percentage 
 
    
 
Lean Body Mass 
Increase in lean body mass over time was significant (F1,33=7.206, p=0.011, 
2
p=0.179).  There 
was no significant group difference (F1,33=0.023, p=0.880, 
2
p=0.001), and no interaction effect 
(F1,33=3.177, p=0.084, 
2
p=0.088).  Lean body mass pre and post test values are graphically 
























Figure 2.  Mean Lean Body Mass 
 
Fat Mass 
There was significant difference over time in fat mass (F1,33=0814, p=0.017, 
2
p=0.160).  There 
was no significant group difference (F1,33=0.002, p=0.962, 
2
p=0.000), and no significant 
interaction effect (F1,33=0.234, p=0.632, 
2
p=0.007).  Fat mass values pre and post are 





















Discussion of Results 
The present study demonstrated the effects of resistance training on a population of persons 
with T2D.  Mean percent body fat percent decreased significantly in the treatment group from 
41.3 to 40.1%, and decreased significantly in the control from 40.78 to 40.06%. Lean body mass 
increased significantly from 53.11 to 54.62 kg in the treatment group, and the control group 
increased significantly by from 53.11 to 53.41 kg.  Fat mass decreased significantly in the 
treatment group from 39.02 to 37.83 kg while increasing in the control group from 39.11 to 
38.32 kg.  There was no significant difference between the two groups.  Significant strength 
changes seen in the treatment group ranged from increases of 54% for bicep curl to a high of 















Similar in trend to the biceps and plantar flexion results, lower body exercises generally showed 
greater strength gain than upper.  Studies examining body composition changes related to 
resistance training, like the present study, are far fewer than aerobic training or purely strength 
training in the older type 2 diabetes population.  However, those that exist are relatively in 
agreement with the mean values of the present study (Daly et al., 2005, Ibanez et al., 2005, 
Dunstan et al., 2002).  The exception to this is that strength gains, regardless of study length, 
were generally less in other studies.  
 Daly et al. (2005) demonstrated similar results in a population of 35 older adults with 
T2D and a similar mean age of 67.4 years.  Unlike the present study, nutritional modification 
was a part of the treatment intervention while the control was purely a nutritional weight loss 
group. Relative strength gains were much lower compared to the present study even though the 
gym based resistance training portion of the study was six months in length and conducted three 
days a week like the present study.  Upper body mean strength increased 43% and lower body 
mean strength increased 33%.  Fat mass decreased by 7.4 kg and lean mass increased 0.9 kg over 
six months.  While the resistance training protocol in this study was similar to the current study, 
the length was far longer and dietary modification was likely a large factor as well.  
 Herriot et al. (2004) examined a similar eight week resistance training protocol with 
additional flexibility training on participants with T2D.  The comparison group in this study was 
a group of non-diabetic sedentary adults performing the training protocol as opposed to not 
training like the present study.  Mean ages of diabetic subjects and non-diabetic subjects was 
50.6 and 54.7 years, respectively.  Similarly to the present study, training was performed 3 days 
each week.  Upper and lower body strength gains observed were less than the present study at 
36% and 41%.  Body composition, however, was not measured in this study. 
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 Nine adults with T2D participated in a twice-weekly progressive resistance training study 
for sixteen weeks (Ibanez, et al. 2005).  The mean age of participants was similar to the present 
study at 66.6 years.  Mean body fat percent decreased by 1.6%, similar to the present study.  
Upper and lower body strength gains observed were far less than the present study at 18.2% and 
17.1%, respectively.   
 A study by Dunstan et al. (2002) examined the effects of a high intensity progressive 
resistance training program on participants with T2D, mean age 67.6 years.  After six months of 
three training days per week, mean fat mass decreased 2.4 kg and mean LBM increased 0.5 kg.  
While the decrease in fat mass was greater than the present study, the change in LBM was 
minimal in contrast.  Nutrition based weight loss was also a part of the study, confounding the 
comparison to the present study.  Mean upper and lower body strength increased by 43.2% and 
33.0%, respectively.  Strength gains here are again lower than in the present study. 
 Castaneda et al. (2002) examined the effects of a sixteen week progressive resistance 
training program on a community dwelling population of older adults with T2D.  Their mean age 
was 66 years, and they participated in training three days per week.  Similar to the present study, 
mean fat mass decreased only 1 kg, while mean lean body mass increased 1.2 kg.  Mean strength 
in this study was averaged as whole body strength and increased 33%, again lower than the 
present study. 
 The fact that no significant differences in body composition specifically attributable to 
resistance training were observed in this study may be due to study limitations like diet and 
additional physical activity combined with the relatively short duration of the study.  Previously 
cited resistance training studies, however, demonstrated that positive changes in body 
composition could be achieved from programs sixteen weeks to six months in duration.  Some of 
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the limitations cited within the present study such as unknown diet and unknown additional 
physical activity of participants could account for why no significant changes were seen between 
groups over the course of the intervention. Decreases in physical activity outside of the training 
program to compensate for the increased energy expenditure could be a reason for the training 
group not demonstrating significant change from controls.  This phenomenon has been 
demonstrated in the research (Mantho et al. 2010).  Individual responses to exercise training have 
been shown to vary with respect to energy intake compensation and may have contributed to the 
lack of group difference seen in the present study (McLaughlin et al. 2006, Church et al. 2009).  
Seasonal changes have been shown to decrease physical activity during the winter (Buchowski et 
al., 2009, Hamilton et al., 2008). Since this study was conducted from January to the end of 
February, the possibility exists that together with a compensatory decrease in physical activity, 
training group participants engaged in less physical activity outside of training   On the other 
hand, the winter in which this study was conducted was unusually warm and sunny for the 
northwest region.  This may have given rise to the ability for control group participants to engage 
in more physical activity outdoors.  The subjects being studied may have had lifestyle changes 
by the control group which may have led to their improvement over the course of the eight 
weeks. Tuomilehto et al. (2001) cited the lifestyle effect of study participation as a possible 
source of bias among controls within the first year of assessing control group participants in their 
weight loss study for persons with impaired glucose tolerance.  Between-day tests using the 
BODPOD have demonstrated less reliability than same-day tests (Anderson, 2007) and may also 
have contributed to the absence of group differences, although the present study used estimated 




Summary of Results 
 The results demonstrated a significant decrease in body fat percentage as well as a 
significant increase in lean body mass over time for both the resistance training and control 
groups.  Since these differences were not significant between treatment and control groups, the 





Summary, Conclusions and Recommendations 
Summary 
 Increased waist circumference, increased waist-hip ratio, and increased abdominal 
adiposity are characteristics of persons with T2D (Han et al., 1998, Azuma et al., 2007).  
Because of this, it is important to understand how body composition can be modified through 
training to potentially aid in treatment.  Prior research has demonstrated the effectiveness of 
resistance training in decreasing adiposity and increasing lean body mass in diabetic populations 
(Herriot et al., 2004, Ibanez et al., 2005).  In this study, examining the effects of resistance 
training on the body composition of persons with T2D was the focus.  Subjects were assigned to 
either a resistance training protocol group or a control group for the duration of the eight weeks. 
 The subject population included forty-one participants all of whom had been previously 
diagnosed with T2D.  Due to attrition, seventeen treatment group members and eighteen control 
group members remained.  The training protocol was eight weeks in length with participants 
resistance training three days per week.  Details are located in appendix A.  Pre and post tests to 
determine subjects’ body composition were conducted using the BODPOD™.  To determine 
statistical significance of whether or not resistance training was effective in modifying body 
composition, a two-way ANOVA with repeated measures was applied.  The mixed design 
evaluated the repeated factor of pre vs. post testing and the fixed factor compared treatment 






 The ANOVA showed significant differences in some but not all of the variables.  While 
there were significant differences in both body fat percentage and lean body mass over time, no 
significant difference existed between the control and treatment groups as a result of the 
resistance training intervention. 
 The results of this study suggest that resistance training may be helpful in promoting 
positive changes in body composition.  However, the fact that no significant difference existed 
between treatment and control groups indicates that other factors may have been involved.  
Specifically, there were unexplained improvements in body composition measurements in the 
control group that accounted for no group differences.  This may have been attributable to 
instrumentation errors or lifestyle changes that the control group instituted in preparation for the 
testing. 
Recommendations 
 Recommendations for further research. 
1. Repeat the study design using a 16 week or longer resistance training protocol 
to allow more time for potential changes in body composition to occur. 
2. Add an additional group engaged in both resistance and cardiovascular 
exercise training. 
3. Repeat the study with a larger sample size. 
4. Monitor energy intake. 




Recommendations for application of findings 
 The data collected during this study may be of use to exercise and healthcare 
professionals who work with special populations.  While the timeframe of involvement in this 
study showed a positive effect on body composition, the lack of significant resistance training 
effect suggests that additional training time and/or dietary modification may be necessary to 
promote desired changes in body fat.  The possibility exists that the control group’s exposure to 
testing of body composition and anthropometric measurements, as well as their voluntary 
participation in the study led to lifestyle changes.  Weight and body composition results were 
important to participants, and almost all expressed anticipation for the second test to see if they 
had made improvements.  Other possible behavioral changes from the training group include 
decreases in physical activity outside of the program to compensate for the increased energy 
expenditure, a potential reason for the training group not demonstrating significant change from 
control.  This phenomenon has been demonstrated in the research (Mantho et al. 2010).  
Tuomilehto et al. (2001) described the effects on control group participants of being studied with 
respect to T2D related lifestyle changes, and the possibility of this group modifying lifestyle due 
to study involvement exists.  Individual responses to exercise training have been shown to vary 
with respect to energy intake compensation and may have contributed to the lack of group 
difference seen in the present study (McLaughlin et al. 2006, Church et al. 2009).  Although 
changes in season have been shown to decrease physical activity in the research (Buchowski et 
al., 2009, Hamilton et al., 2008), the unusually warm and clear winter months during the study 
may have allowed control group participants’ greater availability to outdoor physical activity. 
These are all relevant factors in their own right that should be considered in attempting to 
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This is to certify that I,  , 
hereby agree to participate as a volunteer in a scientific investigation as an authorized part of the 
education and research program of Western Washington University under the supervision of Drs. 
Knutzen, Brilla, Row, Lindsey, Freeman and Li.  
 
Purpose of the Study: 
The study in which I will be participating is designed to determine the role of strength and 
cardiovascular training on blood sugars, heart rate variability and blood pressure, physical 
function, activity level, health status, pain, depression and psychosocial factors. I understand 
that this study is directed towards improving the health of persons with diabetes by studying the 
role of physical activity in improving a number of different physical and psychosocial 
parameters.   Specifically, the purposes of this research study are to explore: 
1. how physical activity participation impacts physical function, physiological 
characteristics, and perception of pain in  people with type 2 diabetes 
2. how people with type 2 diabetes view their illness  
3. the confidence of persons with type 2 diabetes in terms of managing the disease and 
physical activity 
4. the self-perceptions of stress, depression, and social networks as people go through with 
diabetes  
5. how people cope with their diabetes, and  
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6. how these factors affect their blood sugar levels as well as how they care for their 
diabetes  
Procedures to be followed: 
 
I understand that males and females will be invited to participate in this study involving strength 
training and/or cardiovascular exercises.  I understand that in order to participate in this study:  
 I must be over the age of 18 years,  
 I must have had type 2 diabetes for at least 1 year or more,  
 I must have had an A1c level drawn within the past 30 days  
 I must be willing to dedicate three or five days/week over 8 or 16 weeks to the study program,  
 
I understand that I will be participating in one of the three training groups listed below: 
 Group A:  A group that will participate in high resistance weight training 3 days/week from 
January 14, 2008 to June 6, 2008 with testing dates on January 12, 2008, March 15, 2008, and 
June 7, 2008.  
 Group B: A group that will participate in  high resistance weight training 3 days/week from 
April 7, 2008 to June 6, 2008 with testing dates on January 12, 2008, March 15, 2008, and 
June 7, 2008.  
 Group C:  A group that will participate in high resistance and cardiovascular training 5 
days/week from April 7, 2008 to June 6, 2008 with testing dates on January 12, 2008, March 
15, 2008, and June 7, 2008. 
I understand that the study will require me to complete forms before the first testing date and that I must 
attend three test dates (January 12, March 15, June 7) and also attend training sessions. The  activities will 
be as follows: 
1) Prior to attending the first test session (time commitment: ~1.5-2.0  hours):  
 I will read and sign the informed consent form.  
 I will obtain my physician’s consent for participation in the program. I understand that my 
physician is required to read this informed consent form prior to authorizing my participation 
in the program 
 I will obtain my most recent fasting glucose and results of my A1C test from my physician.  
 I will complete the medical background form and the hold harmless agreement 
 I will complete the questionnaire packet which includes 10 different questionnaires. 
a. The study consists of completing 10 questionnaires in a booklet. It should take about 1.0-
1.5 hours to complete the questionnaires. The questionnaires evaluate the following 
topics: 
A. your physical activity habits,  
B. your overall health status,   
C. how diabetes affects your daily life,  
D. your feelings and thoughts during the last month,   
E. how confident you are in your ability to manage your diabetes, 
F. whether activities over the past week have generated feelings of depression,  
G. how confident you are in your ability to perform particular activities,  
H. how well you feel you have coped with your diabetes in the past and how you have 
contact with people closest to you,  
I. how you think about your social life, and  
J. the confidence you have in your ability to exercise regularly.  
2) Test sessions (January 12, March 15, June 7) (time commitment: ~2  hours):  
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 Upon arrival at the first test session, my forms and medical clearance will be reviewed by the 
experimenter for final clarification or additional information. Any questions that I have will 
be answered at that time. 
 I will obtain my most recent fasting glucose and results of my A1C test from my physician 
prior to each test session.  
 I will be tested in the following areas: 
a. Physical Examination: This will include measurements of my height, weight, and body 
girth. 
b. Heart Rate Variability:  This will include lying still on a padded examination table 
for approximately 5 minutes with four electrodes placed on my right and left wrist and 
ankle.  
c. Orthostatic Hypotension Response: This will include blood pressure measures with a 
cuff placed on the arm. Heart rate will be measured over 60 seconds by finger pressure at 
the radial artery.  The blood pressure and heart rate measures will be taken after 2 
minutes in each of three positions:  supine, sitting, and standing.   Blood pressure and 
heart rate will be measured again upon quickly rising from a cot after 10 minutes in the 
supine position, after quickly rising from a chair after five minutes of sitting, and while 
standing straight against a wall after a period of two minutes.   
d. Body Composition: Before completing this test, I will be asked to refrain from eating 4 
hours prior to testing and to void my bladder upon arrival at the test. The test will include 
sitting in a BOD POD chamber with a nose clip and swim cap applied. The BOD POD is 
an enclosed space that will measure my body composition via air displacement.  I will be 
asked to sit in the chamber and it will not feel any different than sitting outside the 
chamber. I may experience discomfort due to the enclosed space but there is a window 
that will allow me to signal the experimenters if I am bothered by the confined space.  
Two trials of 45 seconds each will be taken and a third trial will be taken with 
inconclusive results. A final trial will be taken as I sit quietly and breathe normally 
through a disposable tube for 4-5 breathes followed by two quick light pants with the 
airway blocked.  
e. Perceived Pain:  I will be asked to fill out a pain questionnaire with the assistance of a 
researcher who will answer any questions and who will verbally read the instructions to 
me.  
f. Functional Measures 
1. Chair Stand  (Lower Extremity Strength): I will be asked to sit on a chair (seat height 
= 17”) with my knees bent at 90 degrees, my feet flat on the floor, and my arms 
crossing your chest. In 30 seconds, I will stand up and sit down as many times as I 
can without rocking. 
2. 8-foot up and go (power, agility and strength): I will be seated in a chair and will get 
up and go down to another chair that is 8 feet away. I will walk around the chair and 
come back and sit in the original chair as fast as I can. 
3. Stair Ascent/Descent: I will walk unassisted up and down a series of stairs.  Trials of 
my natural speed and my fastest speed will be conducted.   
4. Balance Tests:  
i. The experimenter will lead me through a variety of balance tests, many of which 
will be conducted on a force platform that measures my balance. These tests 
include standing on one foot, standing with my feet together and eyes closed, and 
standing with my feet held heel to toe. I will also be asked to perform a leaning 
balance test, where I will lean forward and backward as far as I can without 
taking a step. Lastly, I will be asked to perform a rapid step placement test, where 
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I will place my foot on top of a step as fast as I can, while standing on the force 
platform.   
ii. I may be asked to wear a small motion sensing devices on my hips, back, and 
head while I walk naturally across the floor, and up and down a set of stairs.  
These motion sensors attach to a pack that fits around the waist and transmits the 
motion data to a laptop computer.   
5. Endurance Walk: I will walk as far as I can in six minutes.   
6. Timed Walking Test: I will walk through a marked off 20 meter distance as fast as I 
can.   
 The same tests will be repeated on all test dates (January 12, March 15, June 7) 
 
3) Training sessions  (time commitment: ~1.0  hour on MWF for 8 or 16 weeks in the weight 
training groups;  ~1.0  hour on MTWRF for 8 weeks in the weight training/cardiovascular group):  
a. I will be enrolled in either A) a strength training program for 16 weeks, B) a strength 
training program for 8 weeks, or C) a strength and general physical activity program for 8 
weeks.  I understand that my allocation to the exercise program will be random – I have 
an equal chance of being placed in group A, B, or C.  Both of  the strength programs will 
involve the completion of an individualized high resistance training program that will be 
held on Monday, Wednesday, and Friday.  If I am enrolled in the strength and general 
physical activity program I will meet to complete the individualized high resistance 
training program on Tuesday and Thursday and on Monday, Wednesday and Friday I will 
participate in a general physical activity.  
b. I will wear comfortable clothing to the sessions and try and wear flat rubber soled shoes 
or athletic shoes so that I can safely and comfortably walk and push on the weight 
machines and perform the exercises. 
c. I will be asked to follow the procedures described below if I am enrolled in the Strength 
Program only: 
i. The training program will take place in the Carver Gym Room 61, Western 
Washington University.  The program will run for eight or sixteen weeks. I will 
be asked to leave the program if I miss three consecutive sessions or four total 
sessions.  Each training session will begin with a series of stretching exercises 
that will stretch the arms, the legs, and the trunk.  The flexibility exercises that 
will be used include the back scratch test and horizontal flexion and extension for 
the shoulder, hip flexion and abduction/adduction from the supine position, knee 
flexion and extension stretching, and plantar flexion and dorsiflexion stretching.   
ii. I will participate in a high resistance weight training program for three days a 
week.   In the first week of the program I will be instructed on the performance of 
each exercise and will perform 20-30 repetitions of each exercise using a small 
amount of resistance (10-30 pounds).  During the first week, the experimenter 
will assist me to determine maximum strength on each exercise.  A predicted one 
repetition maximum (Pre-1RM) will be determined by having me select a weight 
that can be lifted 8-10 times.  The amount of weight and the number of 
repetitions will be entered into an equation to predict a repetition maximum (Pre-
1RM)  This number will be used to determine the weight I lift each week and the 
Pred-RM will be measured every two weeks.  
iii. In the second week of the program I will be asked to perform each lift with a 
weight that is 50% of the Pred-1RM.   During the remainder of the program, the 
resistance will be increased weekly by 10% up to a load that is 80% of the Pred-
1RM.  The PRED-1RM will be measured every two weeks and the weight will 
be adjusted accordingly.  The exercises can be completed in any order, and I will 
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be asked to complete eight repetitions followed by a rest.  This is known as a set.  
One to three sets will be performed for each exercise.  For example, three sets of 
one exercise will involve 24 repetitions with a rest after every eight repetitions (3 
sets of 8 reps).    
iv. All exercises will be performed on a cable weight machine.  The exercises to be 
performed include chest press, triceps press, lat pull-down, overhead press, leg 
extension or press, arm curl, row/rear deltoid, hip flexion, hip extension, hip 
abduction, hip adduction, plantar flexion, and dorsiflexion.  If I am unable to 
move the minimum amount of weight on the machine (5 pounds), I will be asked 
to just push against the machine and work up to moving the bar.  I will be 
instructed individually on each exercise and records will be maintained for each 
session.     
v. As instructed, I will perform each lift with proper breathing and will not hold my 
breath at anytime during the lift.  I recognize that if I hold my breath while I am 
lifting the weight it might increase my blood pressure unnecessarily.  To control 
for breathing and to keep the speed of the lifting controlled, I will count to four 
when I push the weight and count to six when I lower the weight back down. 
vi. I will inform my trainer about any soreness or pain that I experience.   
vii. I will also inform the trainer if my health has changed for any reason.   
d. I will be asked to complete the following procedures if I am enrolled in the Strength and 
General Physical Activity Program.    
i. All of the procedures for the strength program described above will apply except 
I will only participate in strength training two days a week.   I will participate in 
the strength program on Tuesday and Thursday and the general physical activity 
programming on Monday, Wednesday and Friday.  Each training session will 
begin with a series of stretching exercises that will stretch the arms, the legs, and 
the trunk.  The flexibility exercises that will be used include the back scratch test 
and horizontal flexion and extension for the shoulder, hip flexion and 
abduction/adduction from the supine position, knee flexion and extension 
stretching, and plantar flexion and dorsiflexion stretching.   
ii. The general physical activity training session will include some form of 
cardiovascular exercise performed at a moderate intensity for 30 minutes or 
more.  Following the stretching session, participants will walk or will exercise on 
a machine.  On the machine, participants will start with a slow 5 minute warm up 
followed by the main exercise session and finished off with a slow cool down in 
the last 5-10 minutes. The core cardiovascular workout will start at 5 minutes at 
the start of the program and work up to 30-45 minutes over the course of 8 
weeks.  
iii. I will inform my trainer about any soreness or pain that I experience.   
iv. I understand that I need to provide the trainer information about how my body 
feels and that I should never be exercising in pain or be unable to speak while I 
am exercising. I understand that I will be starting slowly and then working a little 
harder each week by increasing the duration of my exercise session.  
v. I will also inform the trainer if my health has changed for any reason.   
 
Discomforts and Risks: 
I understand that the procedures to be used in this study are considered to be safe. The risks associated 
with the evaluation of body composition in the BodPod and with the blood pressure and heart rate 
measurements are minimal.  
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I understand that there are risks of injury due to accidents during the performance of the functional 
measures.  The adhesive tape used to attach the motion sensors to my skin may cause some skin irritation 
in cases of very sensitive skin.  
I understand that, as with any exercise program, there are risks of injury due to accidents during the 
exercise activities. There is a risk of transient muscle soreness that is a normal result of the beginning of 
many exercise programs and I understand that I might experience some muscle soreness that should 
disappear after a period of rest between sessions.  There is also a slight risk that trauma to the bone, such 
as fractures, or to the muscle or joint could result from an abnormal response to the exercise activities.  I 
understand that if an exercise session or test is painful, I can stop at any time.   
I understand that there is the possibility that I may feel uneasy about answering the questionnaires and 
thinking about how my type 2 diabetes is affecting my life.  I understand that my responses will be kept 
strictly confidential. 
If I feel I cannot or should not perform any of these tasks, I should not participate in this study.  
Benefits to Me: 
I understand that there may not be any direct benefits to me as a result of participating in this study.  I 
understand that one possible benefit of participating in this study is that a free evaluation of certain 
aspects of my function and health status will be performed. It is possible that I may gain a better insight 
into my diabetes because of thinking about living with diabetes.    
Potential Benefits to Society: 
By participating in this study I will be contributing to research that aims to increase scientific knowledge 
about the characteristics and factors associated with physical activity and diabetes.  I understand this 
research may be of use to the public because it may give insight into what effects people to care for their 
diabetes and may assist health care providers to find ways to help inspire people to take correct actions to 
care for their diabetes. Inspiring people to take care of their diabetes may reduce acute and chronic 
complications of diabetes. This may lead to a better quality of life. 
 
Statement of Confidentiality:           
I understand that any data or my answers to questions will remain confidential with regard to my identity.  
I understand that the research team will follow strict rules to protect my privacy at all times during and 
after this study.  I will be assigned a unique ID number and only that number will be associated with my 
data.  My ID number and matching name will be kept in a locked file in a secure area.  Only the 
investigator and his/her assistants will have access to my identity and to information that can be 
associated with my identity.  In the event of publication of this research, no personally identifying 
information will be disclosed. 
 
The investigation and my part in the investigation have been defined and fully explained to me by Drs. 
Knutzen, Brilla, Row, Li, Freeman, or Lindsey or their assistant and I understand his/her explanation.  
The procedures of this investigation and a description of any risks and discomfort have been discussed in 
detail with me and I understand that a copy of the signed consent form will be provided to me.  
Right to Ask Questions: 
I have been given an opportunity to ask whatever questions I may have had and all such questions have 
been answered to my satisfaction. 
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I understand that I am free to deny any answers to specific items or questions in interviews or 
questionnaires.  If I have any questions about this study, I can contact Kathy Knutzen, Ph.D., at the 
contact information listed on the front page of this consent form. 
 
I understand that for additional information about my rights as a research participant, I may contact Geri 
Walker, WWU Human Protections Administrator, at:  
 
Geri Walker 
Research and Sponsored Programs  
Old Main Building 530 
Western Washington University 
Bellingham, WA 98225-9038 
(360) 650-3220 
Compensation: 
I understand that I will receive no compensation for my participation in this study.   
 
Event of injury: 
I understand that emergency medical care will be summoned in the event of injury resulting from this 
study.  In the event of adverse effects related to this study, I understand that I shall contact Geri Walker at 
the office listed above.  I also understand that I am not waiving any rights that I may have against WWU 
for injury resulting from negligence of the University or investigators.   
Voluntary Participation: 
I understand that my participation in this study is voluntary, and that I may withdraw from this study at 
any time by notifying the investigator.  I also understand that my participation may be terminated by the 
investigator if I do not fit any of the pre-determined subject categories or if he or she feels that my 
personal well-being is in question. 
This is to certify that I am over the age of 18 years, and I consent to and give permission for my 
participation as a volunteer in this program of investigation.  I understand that I will receive a signed copy 




              
    Volunteer’s printed name     Date 
 
              
    Volunteer’s signature      Date 
 
 
I, the undersigned, have fully explained the investigation to the above subject. 
 
              




              





PERMISSION TO USE A PHOTOGRAPH, VIDEO, LIKENESS, VOICE OR STATEMENT  
   
Western Washington University  MAY or  MAY NOT (check one box ) use my photographic or 
video image, likeness, voice or statement, in whole or in part, without limitation or compensation, for use 
in Department of Physical Education, Health and Recreation (PEHR) newsletters, publications or web 
sites.  Images may be modified or retouched as needed.  
 
Western Washington University  MAY or  MAY NOT (check one box) use my name to identify the 




       
Name (please print)      
 
             













  STRENGTH AND DIABETES 2008 
 
NAME:                            __                         _____     BIRTHDATE: ______________________            
ADDRESS:  _____________________                                                                                                        
CITY:                                                        ZIP:_____________                                          
 
PHONE:                                AGE:           HEIGHT:            WEIGHT: _________       
 
EMAIL:______________________________________________________________     
 
PHYSICIAN:_________________________________________________________                            
PHYSICIAN'S ADDRESS: _________________________________                                              
 
PHYSICIAN'S PHONE: __________________________________             
 
EMERGENCY CONTACT PERSON:                                RELATIONSHIP:_____________            
EMERGENCY CONTACT PERSON PHONE:________________________________              
 
TRAINING SESSIONS (Circle ALL Available Quarters  & Note your preferred session) 
Session 1:  Jan-June 2008 
3 days/week  
strength training 
Session 2: March-June 2008 
3 days/week  
strength training 
Session 3: March-June 2008 
5 days/week  





TRAINING TIMES (Circle ALL Available Times & Note your preferred time) 
8 - 9 am  
M/W/F   
9 - 10 am 
M/W/F   
10 - 11 am 
M/W/F   
11 - 12 pm 
M/W/F   
12 - 1 pm  
M/W/F   
6-7 pm  
MWF 
 
All participants in the program must complete the following documents (Check off when completed): 
 
 
1. Medical Background Form 
 3. Program Description and Consent (including 
Physician's Clearance for Participation) 
 2. Acknowledgement of Risk and 
Hold Harmless Agreement 
 4. Questionnaire Packet 
It is suggested that your physician assist you with the medical background form in order to provide us 
with accurate information on your medical history.  Please also share the Program Description with 
your physician because it will provide him/her with a description of the study, allowing for a more 
specific recommendation concerning your participation in the exercise program.  You cannot 
participate in the program without a medical clearance. 
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1. Have you been diagnosed with any of the conditions listed below?  If so, place a check by the 
condition, and provide a date (month/year) when you were diagnosed by a medical 
professional. 
 
 Condition Month/Year   Condition Month/Year 
 Anemia or Blood 
Disorder 
   Multiple Sclerosis  
 Angina Pectoris            Myocardial 
Infarction 
 
 Anxiety    Neuropathy  
 Aortic Stenosis                    Osteoarthritis 
Where? 
 
 Arrhythmia    Osteoporosis  
 Arterial Vascular 
Disease 
   Parkinson's Disease  
 Asthma    Pulmonary Disease  





   Sciatica  
 Cancer 
Where? 
   Stroke  
 Congestive Heart 
Failure 
   Tendonitis 
Where? 
 
 Coronary Heart 
Disease 
   Thyroid 
Irregularities 
 
 Dementia    Tremors  
 Depression    Valvular Heart 
Disease 
 





     
 Gastrointestinal 
Disease 
   OTHER 
CONDITIONS? 
 
 High Cholesterol      
 High Blood 
Pressure 
     
 Hypertension      
 Kidney Disease 
 
     
 
 




 If no, what kind of aid do you use?                 
 
 
 How often do you use the aid? 
 
 
3. Do you have low back pain? Yes or No? (Circle one)  
 
 If yes, have you received treatment for low back pain? 
 
 
  When?                 
 




 Do you currently have low back pain? Yes or No? (Circle one) 
 
 
4. Have you ever had a joint replaced?  Yes or No? (Circle one) 
 
 
 If Yes, what joint(s), and when was the surgery (month/year)? 
 
 
                                                 













8. Are you currently receiving any medical treatment for any condition? Y/N 





9. Are you currently receiving any physical therapy or chiropractic treatment for any 
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10. Have you ever smoked?     Y/N      
 
a. If yes, how much and how many years? 
 
 
b. Do you presently smoke? Y/N 
 
 
11. Do you drink alcoholic beverages? Y/N   
 




12. Do you ever experience tightness, pressure or pain in the chest, shoulders, arms, neck or 
jaw either during exertion or at rest? Y/N   
 




13. Do you ever experience dizziness, lightheaded spells, or fainting spells? Y/N 
 
If yes please explain 
 
a. Have you ever been dizzy or lightheaded during or after exercise?  Y/N 
 
b. Have you ever passed out during or after exercise? Y/N   
 
c. Have you ever experienced chest pain during or after exercise?  Y/N 
 
d. Do you tire quicker than your friends during exercise?  Y/N 
 
e. Do you cough, wheeze, or have trouble breathing during or after exercise?  Y/N 
  
14. Is there any other condition not mentioned here that might affect your ability to exercise or 
be aggravated by exercise?  Y/N    
 






15. Do you wear corrective lenses? Y/N   
 





16.  Are you taking any medications?  Yes or No? (Circle one) 
 




















17.    Do you self-monitor your blood glucose?   Y/N 
 
 If yes, what was your last reading? __________________ 
  Date of last reading:   _________________ 
 
 What was the last fasting glucose reading that was measured at the lab by your  
 physician?  ____________________________ 
  Date of last lab result for fasting glucose; _______________________  
 
 
18.  What was your last A1c test result?   
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1. What is your research question, or the specific hypothesis? 
Type II Diabetes is reaching epidemic proportions in the United States.  The Centers for Disease 
Control estimates that in 2005, 21 million Americans (7%) had diabetes with more than 6 million of 
this group who did not know they had it (http://apps.nccd.cdc.gov/DDTSTRS/FactSheet.aspx).  In 
2005, another 41 million Americans were considered to have pre-diabetes, a precursor to Type II 
diabetes.  Type II diabetes is related to a number of health conditions including heart disease and 
stroke, blindness, kidney and nerve damage. The incidence of Type II diabetes increases with age 
and is more prevalent in specific ethnic groups such as American Indians and Alaska Natives.    
Hypertension, obesity, depression, and social isolation are also conditions associated with persons 
who have Type II diabetes.  Finally, orthostatic hypotension (OH) and heart rate variability (HRV) is 
also common in diabetic subjects and are related to autonomic dysfunction. 
This study will examine changes in health status and well-being and overall physical activity patterns 
as well as other physiological, functional, psychological, and social changes occurring in persons with 
Type II diabetes who engage in a strength or combined strength and aerobic program.   Using a 
delayed treatment design, the following research question will be evaluated: 
 
What is the effect of participation in different strength and strength/physical activity programs 
on selected health, physical activity, functional, physiological, and psychosocial characteristics of 





2. What are the potential benefits of the proposed research to the field? 
Physical activity is viewed as a very important component of the treatment protocol for individuals 
with Type II diabetes.  Exercise has been shown to be effective in glycemic control and persons 
participating in aerobic, strength or combined physical activity programs have demonstrated a 
positive change in glucose control as indicated by lower glycosylated hemoglobin tests (HbA1c).  
While physical activity improves the glucose transport system by increasing insulin sensitivity, there 
are also a number of other benefits related to improvement of health.  In particular, blood lipids 
ratios and hypertension can be improved with a regular program of physical activity.  Participation in 
regular physical activity can also be very effective for delaying the onset of Type II diabetes.   
Low muscle strength is a common characteristic of individuals with a high number of metabolic 
risk factors or with Type II diabetes.  Low strength can be related to functional impairment seen in 
tasks such as walking, chair stands and other daily activities.  Strength must be maintained at a minimal 
baseline level in order to generate enough force to control body and segment mass effectively.  As 
adults lose strength they must use a greater percentage of their maximum strength to perform 
activities, and many older women, in particular, may be at functionally important strength related 
thresholds.  While decreases in strength below a threshold level can lead to functional impairment, an 
increase in strength can have a very positive influence on function.  Many functional tasks performed 
on a daily basis involve moving the body mass or some other weight in a timely manner (i.e. gait, stair 
climbing, sit-to-stand, carrying).  The time to complete the tasks is an important indicator of function 
and is a reflection of balance, coordination, and strength.  Strength makes a contribution in a timed 
functional task by providing a more efficient neuromuscular system so that there is optimal integration 
of the neuromuscular properties and physical performance so that force can be generated quickly in the 
task.  Strength also impacts the level and amount of cardiovascular exercise that older adults can 
participate in. For example, a walking program is only successful if there is enough strength in the lower 
extremity to support a continuous level of activity.  Poor physical condition can be a precursor to 
limited physical activity patterns or limited physical activity can be a precursor to a poor physical 
condition. This in turn influences overall quality of life.  This study will examine the role of strength 
training on a number of functional, physiological, and psychosocial variables.  The results of this study 
will help determine the most effective strength training time period necessary to see specific changes 
across a wide range of variables.  Additionally, a general physical activity component will be added to 
the strength training protocol to provide a balanced exercise program. Strength training is important 
for general function and quality of life but general physical activity has also been shown to be 
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important for a number of health reasons.  For adults, it is recommended that they participate in 
moderate physical activity for 30 minutes most days of the week to obtain these benefits.  Be 
evaluating the two strength programs and the combined strength and physical activity program, we 
will be able to provide support for utilizing different modes of exercise prescription for the diabetic 
population.  
Strength training is thought to reduce functional instability and pain in older osteoarthritic 
patients by preventing sarcopenia and by improving the strength and function of the surrounding 
connective tissue (ACR, 2000; AGS, 2001; Hughes et al., 2004; Hurley & Roth, 2000). Several studies 
support that strength training can significantly reduce pain in elderly patients with OA (Baker et al., 
2001; Hughes et al., 2004; O’Reilly et al., 1999; Rogind et al., 1998; Shilke et al., 1996; Suomi & 
Collier, 2003).  Combination exercise programs (aerobic and strength) (Focht, 2006) as well as long-
term exercise programs (Wilder et al., 2006) are also seen as effective for improvement of knee pain 
in individuals with osteoarthritis.  
In the physiology area, there are many potential benefits of exercise for individuals with 
diabetes.  The frequency of heart rate variability (HRV) within the lowest 25th percentile in Type II 
diabetes mellitus subjects was: 82% with autonomic neuropathy, 64% with peripheral neuropathy, 
and 36% with no obvious signs or symptoms of neuropathy (Masaoka, et al. 1985).  Low HRV is a risk 
factor for sudden death and ischemic heart disease in individuals with type II diabetes (Kataoka, et 
al. 2004; Manzella and Paolisso, 2005) and impaired autonomic control is associated with risk of 
cardiovascular heart disease in individuals with diabetes (Liao, et al. 1998).  Low HRV predicts 
atherosclerotic progression is carotid arteries (Gottsater and Ahlgren, 2006) and increased 
atherosclerotic lesions in cerebrovascular disease (Nagata, et al. 2006).  Diminished HRV is 
associated with the metabolic syndrome (MetS), a cluster of risk factors for cardiovascular disease, 
as well (Stein, et al. 2007).  Cardiovascular autonomic control in essential hypertension patients was 
further impaired by Type II diabetes, by lowering of HRV.  Improving cardiovascular autonomic 
function might reduce occurrence of cardiovascular complications in essential hypertensive patients 
with Type II diabetes by improving insulin sensitivity with medication or exercise (Wang, 2006).  
Reduction in total HRV is associated with early stages of diabetic autonomic neuropathy (Flynn, 
et. 2005; Kudat, et al. 2006; Lewis, 2005; Schroeder, et al. 2005; Osterhues, et al. 1998). Orthostatic 
hypotension is complicated in normotensive individuals with type II diabetes, and may associate 
with early stage hypertension (Yoshinari, et al. 2001). Autonomic neuropathy and higher supine 
systolic blood pressure (SBP) values are strong and independent predictors of SBP decrement during 
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acute supine to standing position and sustained orthostasis in individuals with type II diabetes 
(Jarmuzewska, et al. 2006).  Individuals with diabetes have a more precipitous drop in standing BP 
than other groups with orthostatic hypotension (Hilsted, et al. 1981).  Diabetes patients with 
orthostatic hypotension carry a high risk of cardiovascular death.  Diabetic neuropathy is the 
plausible explanation (Luukinen and Airaksinen, 2005). 
The literature supports that exercise training increases HRV (Carter et al. 2003; Faulkner et al. 
2005; Figueroa et al. 2007; Sandercock et al., 2004; Zoppini et al. 2007).  Increased HRV is associated 
with lower cardiorespiratory risk and higher physical fitness.  A protocol involving resistance training 
and diabetes has yet to be evaluated with HRV measurement.  Diabetic people experience greater 
cardiovascular risk.  For this reason, a positive change in HRV may be beneficial to this population.  
This investigation may offer insight to whether efficacy exists for such a training protocol.  Further, if 
an increase in HRV is elicited, resistance training may provide a valuable method for positively 
modifying this physiological measure. Oorhtostatic hypotension is also more prevalent in diabetic 
people. If OH is ameliorated in those who experience it, then the intervention of such a training 
protocol may garner support.  Previous research demonstrated a positive effect of high resistance 
training in older adults (Brilla, et al. 1998). 
It is documented that significant strength gains and positive physiological adaptations occur in 
diabetic people following high resistance strength training.  Improved glucose control and a 
decrease in metabolic syndrome (MetS) factors, such as the lipid profile, may also improve. 
The results of this study will contribute to research that aims to increase scientific knowledge 
about the characteristics and factors associated with physical activity and diabetes.   The 
information obtained on the questionnaires will provide valuable insight into the effectiveness of 
the program in improving people’s general health.  It also adds understanding on how the program 
affects people’s perceptions of their quality of life.  The survey may also encourage participants to 
pay closer attention to their health in many aspects.  Results may provide insight into what 
influences people to care for their diabetes and may assist health care providers to find ways to help 
inspire people to take corrective actions to care for their diabetes.  Inspiring people to take care of 
their diabetes may reduce acute and chronic complications of diabetes.  This may lead to a better 






3. What are the potential benefits, if any, of the proposed research to the subjects? 
Physical inactivity is considered to be a very serious health issue for our nation, with 25% of adults 
physically inactive.  The incidence of inactivity increases with age and the adult with type II diabetes 
is particularly vulnerable to the risks associated with inactivity.  The development of successful 
programming for adults with type II diabetes may delay the progression of type II diabetes and 
provide an enhanced physical capability for performance of tasks of daily living.  The overall benefit 
will also be seen in the prevention and management of diabetes, chronic diseases such as heart 
disease, diabetes or arthritis.  Further, the research design of a wait-list control group is an approach 
that allows the participation of all subjects in the physical activity program being offered, instead of 
a group of subjects being randomized to a traditional inactive control group, and therefore missing 
out on the exercise program.  This approach requires additional effort and resources on the part of 
the research team, and a longer study timeline, but is worthwhile to increase the benefit to all study 
subject, particularly since it does not reduce the effectiveness of the research design.   
4. Answer a), then answer either b) or c) as appropriate. 
a. Describe how you will identify the subject population, and how you will contact key 
individuals who will allow you access to that subject population or database. 
A select group of adults in the local Whatcom County community will be notified of the study 
and invited to participate.  A flyer will be distributed to physicians and to St. Joseph Hospital 
announcing the study for patients who have type II diabetes (See attached).  An ongoing 
announcement will also be placed in the Bellingham Herald.  The announcement will read  
“Do you have Type II Diabetes?  You are invited to participate in a research project at 
Western Washington University which will provide you with a free strength and physical 
activity program. Multiple measurements will be collected both before and after a strength 
or strength/physical activity program. Three Program Options:  A. Strength Training 3 
days/week January 12, 2008 through June 12, 2008; B. Strength Training 3 days/week March  
15, 2008 through June 12, 2008; C. Strength/Physical Activity Training 5 days/week March 
15, 2008 through June 12, 2008. Contact Dr. Kathy Knutzen (650-3055) for more information 
or an enrollment packet.” 
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b. Describe how you will recruit a sample from your subject population, including possible 
use of compensation, and the number of subjects to be recruited. 
Subjects will not receive any compensation for participation in the study.    
 
From the pool of applicants,  a minimum of 60 subjects will be selected to participate in the 
16 week-strength program (Jan-June), the 8 week strength program (March-June) or the 8-
week strength and physical activity program (March–June).  Subjects will be randomly 
assigned to one of the three test groups once availability and eligibility are determined.  If 
more than 60 subjects express interest in the study, every attempt to accommodate larger 
group sizes will be made.  Subjects must meet the minimum requirements of being over the 
age of 18 years, having diagnosed type II diabetes for at least one year or more, be willing to 
provide the results of HbA1c tests taken within the past 30 days, and be willing to dedicate 
3-5 days/week to training.   
c. Describe how you will access preexisting data about the subjects. 
Subjects will provide the results of fasting glucose and their most recent HbA1c 
measurement by their physician.  
5. Briefly describe the research methodology. Attach copies of all test instruments/questionnaires 
that will be used. 
The methods and research interventions that will be applied will take place over three test sessions 
with subjects randomly assigned to three different training protocols: 
 
PRE-TEST: Prior to attending the first test session, subjects will submit a signed informed consent 
form, a physician’s consent form and a medical background form.  These will be reviewed with the 
subjects at their first test session.  Subjects will also be asked to complete a questionnaire packet at 
home.  The packet will be randomly constructed to produce 3 different forms and it will take 
approximately 1.5 – 2.0 hours to complete the questionnaires (See attached questionnaire packet).  
The questionnaires will evaluate: 
 physical activity habits, 
 overall health status,  
 diabetes quality of life,  
 perceived stress,  
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 diabetes self-efficacy,  
 depression, 
 balance confidence, 
 social networking,  
 perceived isolation, and  
 exercise self-efficacy.  
  
TEST SESSION PROCEDURES:  Three test sessions will be scheduled in January, March and June.  The 
same procedures will be followed at each test session and all training groups will participate in all test 
sessions.  Each test session will last approximately 2 hours and subjects will complete the following tests 
and procedures: 
 Upon arrival at the first test session, forms and medical clearance will be reviewed by the 
experimenter for final clarification or additional information. Questions that the subject has will be 
answered at that time.  A final copy of the consent form will be signed for both the experimenter 
and the subject.  
 Subjects will provide their most recent fasting glucose and results of HbA1C test from their 
physician. 
 In a randomized order, subjects will be tested in the following areas:  
g. Physical Examination: This will include measurements of height, weight, and body girth. 
h. Heart Rate Variability:  Measurements of HRV will be collected via EKG during one testing 
session prior to the start of the training program and one session after the training has been 
completed.  Subjects will be asked to lie still and comfortably on a padded examination table 
in the laboratory.  The electrode placement sites are the medial aspects of the right and left 
wrists and the left ankle.  All electrodes are disposable will not be used between subjects 
and will be discarded after each use.  All attachment sites will be prepped with alcohol 
swabs prior to electrode placement in order to insure optimal EKG signal acquisition.  
Subjects will be instructed to stay still and quiet until the examiner tells them the recording 
is completed, but that they can freely interrupt this process at any time if they experience 
discomfort. 
i. Orthostatic Hypotension Response:  At the same testing session for HRV, orthostatic 
hypotension responses will be determined as subjects shift position by observers trained in 
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blood measurements according to American Society of Hypertension standards.  Their 
reliability will be checked by being within + 4 mm Hg, using double hosed stethoscopes, on 
six subjects independent of the study subjects.  Blood pressures (BP) will be obtained using a 
blood pressure cuff on the upper arm.  Heart rate (HR) will be measured by a 60-second 
palpation of the radial artery.  In fixed order, BP and HR will be obtained upon rising from a 
cot after 10 minutes in the supine position, rising from a chair after five minutes of sitting, 
and while standing straight against a wall after a period of two minutes.  Orthostatism is 
defined by the following criteria: decline of 20 mm Hg or more in systolic blood pressure, or 
a 10 mm Hg decline or more in diastolic blood pressure, or relative drops of > 5% in mean 
arterial pressure following a change in posture.   
j. Body Composition:  Body composition will be evaluated using a plethysmography protocol 
with the “Bod Pod”.  Subjects were asked to refrain from eating 4 h prior to testing.  Upon 
arrival to the body composition lab, subjects were asked to void their bladder.  Height was 
measured to the nearest centimeter and weight to the nearest 0.1 kg.  After calibration, 
subjects apply a noseclip and a swimcap and enter the Bod Pod for two trials of 45 seconds 
each.  After two successful trials, subjects are measured for thoracic gas volume by having 
them breathe through a disposable tube and filter with 4-5 normal breaths.  The airway is 
occluded during mid-exhalation and the subject is instructed to make two quick light pants.  
k. Perceived Pain: All participants will complete the McGill Pain Questionnaire.  The testing 
conditions for the MPQ will be held as constant as possible by having the administration 
conducted on an individual basis with assistance from research assistants.  This provides 
assurance that each section is filled out completely and participants have clear instructions 
and questions answered.  The participants were instructed to select the subclasses that 
were applicable to their pain, and then to circle the most appropriate word within the 
subclass that characterized their pain.  
l. Functional Measures – All functional measures will be collected in the Biomechanics Lab 
(WWU) and include the following measures: 
i. Chair Stand  (Lower Extremity Strength):  Subjects will sit on a chair (seat height = 17”) 
with knees positioned at 90 degrees, feet flat on the floor, and arms crossing the chest. 




ii. 8-foot up and go (power, agility and strength) Two chairs are space 8 feet apart. With 
the subject sitting in one chair, on the verbal cue, go, subjects get up and walk around 
the chair and back to sit in the original chair (timed task). 
iii. Stair Ascent/Descent.  Subjects will walk unassisted up three stairs, turn around and 
walk down the stairs.  Three trials will be collected.  The hand rail should not be used in 
the ascent or descent but is available for assistance if necessary.  
iv. Balance Tests.  Subjects will stand on a force platform and be lead through a variety of 
balance tests, including standing on one foot, standing with feet together and eyes 
closed, and standing with feet held heel to toe.  A leaning balance test will also be 
administered which will have the subject lean forward and backward as far as possible 
without taking a step.  Subjects will perform a rapid step placement test, where they will 
be asked to place their foot on top of a step as fast as possible while standing on the 
force platform.  Some subjects will be fitted with an accelerometer on the hips, back, 
and head while walking and performing stair ascent and descent.  The accelerometers 
attach to a pack that fits around the waist and transmits the motion data to a laptop 
computer.   
v. Endurance Walk: Subjects will walk as far as they can in six minutes.  A student will walk 
with them to provide assistance at any time.  
vi. Timed Walking Test: Subjects will walk a 20 meter distance as fast as they can.   
TRAINING PROCEDURES: 
All training programs will take place in the Mature Adult Training Facility, Western Washington 
University. Subjects will be assigned a personal trainer to work with throughout the eight or sixteen 
week training periods and will be encouraged to wear appropriate clothing and shoes to each session.  
All training sessions will begin with a series of exercises which will warm-up and stretch the muscles of 
the trunk, legs, and arms.  The warm-up exercises which will be utilized include the back scratch test and 
horizontal flexion and extension of the shoulder, hip flexion and abduction/adduction from the supine 
position, knee flexion and extension stretching, and plantar flexion and dorsiflexion stretching. 
 
Strength Protocol -8 weeks.  Following warm-up, each subject will perform twelve exercises on weight 
machines.  In the first week of the training program, subjects will be instructed on proper lifting 
technique for each exercise.  They will perform 20-30 repetitions of each exercise using a low amount of 
resistance (10-30 pounds).  During this time period, the experimenter will also predict a one repetition 
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maximum (1RM) for subjects on each exercise.  Subjects will first select a weight where they can 
perform 8-20 successive repetitions.  Subsequently, the experimenter will predict 1RM using an 
equation developed by Bryzycki (1993): weight lifted/1.0278-(0.0278*number of repetitions).  This 
method of 1RM prediction will be used to determine the weight subjects will lift for the remainder of 
the training sessions.  Using a predicted maximum is safer than performing a true max test and is often 
used for unconditioned individuals.  Reassessment of 1RM will occur every two weeks and lifting weight 
will be adjusted accordingly.  In the second week of training, weight lifted will be 50% 1RM determined 
from the previous week.  Weight lifted will increase to 80% 1RM in weeks three through eight.  During 
this time period 3 sets of 8 repetitions will be performed.  Training exercises can be completed in any 
order with each set being followed by a rest period.  Pulse rate and blood pressure will be monitored 
throughout the training period in effort to detect cardiovascular response.   
 
All exercises will be performed on a cable weight machine.  The exercises to be performed include chest 
press, triceps press, leg extension or press, arm curl, row/rear delt, shoulder press, lat pull down, hip 
flexion, hip extension, hip abduction, hip adduction, plantar flexion, and dorsiflexion.  If participants are 
unable to move the minimum amount of weight on the machine (5 pounds), they will begin by just 
pushing against the machine isometrically and work up to moving the bar.  Participants will be 
instructed individually on each exercise and records will be maintained for each session.     
 
Strength Protocol -16 weeks .  The same training procedures as outlined in the 8 week protocol will be 
followed for the 16 week protocol.  From weeks 8-16, the weight lifted will be maintained at 80% 1RM 
with a reevaluation every two weeks. 
 
Strength & Physical Activity – 8 weeks.   Subjects will participate in both a strength (2 days/week) and 
physical activity (3 days/week) program.   The strength program will follow the same procedures 
outlined for the 8 week strength protocol.   
 
The physical activity session will begin with a series of stretching exercises that will stretch the arms, the 
legs, and the trunk.  The flexibility exercises that will be used include the back scratch test and horizontal 
flexion and extension for the shoulder, hip flexion and abduction/adduction from the supine position, 
knee flexion and extension stretching, and plantar flexion and dorsiflexion stretching.  The general 
training session will include some form of cardiovascular exercise performed at a moderate intensity for 
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30 minutes or more.  Following the stretching session, participants will walk or will exercise on a 
machine.  On the machine, participants will start with a slow 5 minute warm up followed by the main 
exercise session and finish with a slow cool down in the last 5-10 minutes.  The core cardiovascular 
workout will start at 5 minutes at the start of the program and work up to 30-45 minutes over the 




6. Give specific examples (with literature citations) for the use of your test 
instruments/questionnaires, or similar ones, in previous similar studies in your field.   
Physiological Measures 
Measurement and analysis using EKG to computer interface is widely used in studies which examine 
heart rate variability.  Studies by Carter et al. (2003), Faulkner et al. (2005), Figueroa et al. (2007), and 
Zoppini et al. (2007) examined the effects of exercise on HRV using such instrumentation.  All of those 
studies involved endurance or aerobic mode of exercise. Of thirteen studies examined in a recent meta-
analysis, eleven involved similar instrumentation to the current investigation (Sandercock et al., 2004).  
The remaining two involved ambulatory EKG devices which were later interfaced to computer.  OH 
criteria are well established (American Society of Hypertension, 1992; Masuo, et al., 1993; Petrella, et 
al., 1989) for postural changes such as the ones proposed for this study, and in head tilt methods. The 
postural changes cause less discomfort than head tilt.  Both of these methods (HRV and OH) have been 
used in previous studies at Western Washington University (Brilla, et al. 1998; Barlond, unpublished 
master’s thesis, 2007) and had been approved by the university human subjects committee.  
 
Body composition is a predictor of metabolic health and fitness and has been studied in type II 
diabetics.  Body composition has been measured as a predictor of insulin sensitivity in studies such as 
Goodpaster et al. (1997) and Goodpaster et al. (2000).  Azuma et al. (2007) have also assessed adipose 
tissue distribution as related to insulin resistance in type II diabetics.  Dube et al (2006) examined body 
fat distribution in a comparison between type I and II diabetics. 
 
Psychosocial measures 
The CES-D is a 20-item self-report, valid and reliable, questionnaire developed by the Center for 
Epidemiological Studies of the National Institute of Health to ascertain depressive symptoms in both 
clinical and non-clinical populations.  It is widely used in the general population for epidemiological 
depression research (Radloff, 1977).  For each item, respondents are asked to report how often they 
experience each behavior, mood, or perception during the previous week.  Response choices, and 
scoring, range from rarely or none of the time (0) to most or all of the time (3).  Four items are worded 
in a positive direction and the score is reversed and added to the other 16 items. *The four items are “I 
felt I was just as good as other people; I felt hopeful about the future; I was happy; and I enjoyed life.”+  
For depression research, the usual scoring is a sum of the item weights, with the greatest possible score 
of 60.  Total scores of 16 and higher most clearly differentiate clinical depression or the likelihood of 
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depression occurring.  There is evidence from a longitudinal study (Ostir et al., 2004) that a positive 
affect (quantified by the ‘positive affect summary scale’: created from four items on the CES-D scale) has 
a protective effect on the risk of becoming frail in an older adult sample, and of reductions in functional 
and physical decline.  Further, pessimism has been found to be associated with low functional 
performance (Brenes et al., 2002).   
Social isolation has been linked to fall risk and fear of falling in older adults (Murphy et al., 
2002), and in a multivariate approach, family network remained significantly associated with decreasing 
fall risk (Faulker, 2003).  The mechanisms for this effect may include support (possibly in the form of 
physical assistance and access to resources), and influential mechanisms (probably including expressing 
concern and advice about hazardous activities or situations) (Faulker, 2003).   
The Balance Confidence ABC scale (Powell & Myers, 1995) is used widely in the functional 
assessment and fall prevention research communities, as it represents the individual’s feeling about 
their physical mobility and balance, which may vary from their actual ability, and allows us the ability to 
factor in the influence of a fear of falling on functional and self-report measures of physical activity.  The 
ABC scale is related to performance measures of balance and mobility, but also provides unique 
information regarding the individual’s perception of their balance and mobility function (Myers et al., 
1996).    
In a recent evaluation of the effect of high resistance weight training on perception of pain by 
older adults, the training group achieved strength gains ranging from 62% -119% and also reported 
decreases in five of the eight pain rating-measures (Knutzen et al., In press). There were no changes in 
the pain scores of the control group (n=19). Results suggest that eight weeks of progressive, whole-body 
weight training has a positive impact on perception of pain in older adults.  It is expected that this result 




In the balance area, exercise intervention studies have begun to show promise in improving balance 
function in individuals with diabetes (Richardson et al., 2001) and in changes in the nervous system that 
underlie motor control (Balducci et al., 2006; Fisher et al., 2007).  The effect of resistance training has 
not been evaluated.  A simple method of categorizing subjects into balance stable and unstable 
categories was validated in a recent large-scale study.  Subjects will be asked to perform 3-trials of 
standing on one foot for 10 seconds, and their performance over all three trials will determine whether 
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they are considered stable or not.  During such trials, a chair and spotters will be nearby for hand holds, 
as needed.  A short physical performance battery (consisting of standing with the feet in various 
positions in order to challenge balance), has been used extensively as an indicator of upper level balance 
function in seniors for years (Guralnik et al., 1994).  This battery of tests has shown some merit in 
predicting the level of functional decline experienced by seniors, and particularly individuals who 
experience the sort of medical problems encountered when experiencing diabetes (such as peripheral 
arterial disease; McDermott et al., 2007).  Poor performance on this test battery has specifically been 
related to fall risk in individuals with diabetes (Richardson, 2002).  The rapid step-up test (Sims & Brauer, 
2000) is a challenge to mediolateral balance control.  The test entails reacting to a start cue, and rapidly 
placing the foot on top of a 15 cm step.  The individual does not step up onto the step (moving his/her 
body weight up onto the step), but rather balances with the weight positioned over the foot that 
remained in contact with the floor.  The outcome measure for this test is the amplitude and velocity of 
the movement of the center of pressure (the average point of application between the forces between 
the foot and the ground).  The ‘leaning balance’ task will be conducted, which requires the subject to 
maintain their knees, hips, and back as straight as possible, and lean as far forward and backward as 
possible, while moving only at the ankles (Binda et al., 2003).  This is a challenge to ankle muscle 
strength, and also to the sensory and motor contributors to balance control, aspects related to 
peripheral neuropathy that are expected to improve with exercise training.  Additionally, this measure 
has been found to be sensitive to individuals’ fear of falling (Brouwer et al., 2004).  Acceleration of the 
head and trunk during gait have been noted to be temporally and spatially different between healthy 
normal individuals and individuals with diabetes, where individuals with diabetes display impaired 
‘rhythm’ in their trunk and head accelerations (Menz et al., 2004).  Measuring acceleration of the body 
during locomotion simply involves fixing accelerometers (motion sensors) to the skin (with tape), and 
having the subject wear a Bluetooth transmitter pack that is hard-wired to the sensors.  The subject can 
then freely move about, and the signal is transmitted to a computer.  The effects of any exercise training 
on improvements in gait stability have not been evaluated.   For force platform measures, 
differences between individuals with diabetes, and particularly diabetic peripheral neuropathy, have 
been noted on measures of sway, where individuals with diabetes show greater sway areas and 
velocities, indicating worse balance control (Boucher et al., 1995; Centomo et al., 2007), and reductions 




7. Describe how your study design is appropriate to examine your question or specific hypothesis. 
Include a description of controls used, if any.  
In an effort to examine the effects of strength training or strength/physical activity 
on health status and overall physical activity patterns as well as other physiological, 
functional, psychological, and social changes in diabetic people, the proposed study 
will use a pre-post delayed-treatment design.  Individuals in the subject pool will be 
randomly assigned to one of three training groups (strength-8weeks; strength-16 
weeks; strength/physical activity-8 weeks).  Subjects in all groups will participate in 
the same three test sessions.  Control group measurements will be taken in the pre-
post testing for the 8 week exercise groups who will begin their delayed strength 
training or strength/physical activity halfway into the 16 week training group.   
 
8. Give specific examples (with literature citations) for the use of your study design, or similar ones, 
in previous similar studies in your field.   
Studies using similar research design include investigations involving older adults and/or diabetic 
people and high resistance training at Western Washington University as well as studies involving 
exercise and HRV and OH studies which have been done with older adults and/or diabetic people at 
Western Washington University and are available in the literature (Brilla, et al. 1998; Carter et al. 
2003; Faulkner et al. 2005; Figueroa et al. 2007; Sandercock et al., 2004; Zoppini et al. 2007).  More 
intervention studies are needed to determine the best exercise protocol that results in improved 
autonomic function for diabetic persons with cardiovascular autonomic dysfunction.  Exercise is 
sometimes the only non-pharmacological treatment suggested (Maser and Lenhard, 2005). 
In biomechanics, repeated measures designs are popular and used regularly to assess human 
performance across multiple conditions.  It is felt that evaluating using a within subjects design or 
even a single subject design, allows for a stronger interpretation of the interventions at the 
individual level.  Schutz et al. (1987) has provided guidance for many exercise science researchers 
utililzing a within subject design, and Bates (1996) highlights many of the problems assessing human 
biomechanics using randomized, fixed designs.  
 
9. Describe the potential risks to the human subjects involved. 
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There are a number of risks associated with participating in strength and general physical activity.  
Possible risks of exercise participation include and are not limited to lightheadedness, shortness of 
breath, muscle soreness, delayed onset muscle soreness, nausea, cardiovascular events, and death.  In 
the strength area, muscle soreness is possible when the resistance is up in the higher ranges (80%).  
There is also a potential for injury to joints or the low back.  And for both the strength and general 
physical activity, the exertion and the higher intensity can raise the blood pressure.  There are 
procedures in place to minimize the risk of injury.  First, each participant must be cleared for 
participation in the program and physicians are asked to read the consent form so they are fully aware 
of the physical demands and tasks associated with the program.  When the subjects are enrolled in the 
program, they are closely monitored by a student trainer.  This includes checking on form, monitoring 
speed of lifting, and checking heart rate and blood pressure at regular intervals.  Each exercise station is 
fit to the participant and the settings are recorded for future sessions.  All participants are provided both 
written and oral instructions on the use of the equipment.  During the exercise, no participant is allowed 
to hold his/her breath and the speed of lifting is controlled by counting.  Lowering speed is slower than 
lifting speed to minimize the potential for injury seen in the lowering action.  All trainers hold current 
certifications in first aid and CPR.    
Subjects may not respond favorably to completing the questionnaires.  There is a slight risk of 
feeling uneasy as subjects think about their illness and how type II diabetes affects their life. 
 
10. If the research involves potential risks, describe the safeguards that will be used to minimize such 
risks. 
The procedures to be used in this study are considered to be safe. The risks associated with the 
evaluation of body composition in the BodPod and with the blood pressure (OH) and heart rate (HRV) 
measurements are minimal.  The measurement of HRV will be performed via a non-invasive 
electrocardiogram (EKG).  Subjects will be required to lie still and quietly in a supine position for 3 to 5 
minutes.  Careful attention will be paid to keep the data collection area quiet and comfortable at room 
temperature.  The attachment sites will include the medial portions of the each wrist and ankle.  During 
the EKG measurements, participants in this study will be lying down supine, still and quiet.  The 
examination table will be at a height which allows each subject to easily translate to and from standing 
and lying positions.  A new table covering and a new set of disposable adhesive-interfaced electrodes 
will be used for each subject.  Data obtained from the EKG will be transmitted to a computer for 
interpretation by the researcher.  The experimenter performing the measurements is a certified CPR 
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provider.  During OH, the subject does quickly change posture from lying to standing or sitting to 
standing, or may be in sustained standing for a few minutes. At all times, two attendants will be 
available to assist the subject, if needed.  The actual recording of blood pressure and heart rate by the 
experimenters to evaluate transitional phase changes is innocuous.  The BodPod measurements will 
take place with the subject in the seated position within the BodPod chamber and the patient comfort 
will be monitored at all times.  In the exhalation test with the airway occluded, experimenters will 
observe the subject for any lightheadedness followed the quick breaths.  
Risks associated with the training portion of this study will be decreased through prescreening of all 
volunteers.  A medical history form, which each potential subject will be encouraged to discuss with 
their physician, will provide information on any preexisting conditions as to allow the experimenter to 
more precisely asses each individual’s risk potential.  All subjects will be required to obtain medical 
permission from their physician to participate in the study.  These forms will be provided within a time 
frame that allows each subject to have adequate time to read the materials, have an examination with 
their physician, and provide accurate responses to all questions. 
When the subjects are enrolled in the strength aspect of the program, they are closely monitored by 
a student trainer.  This includes checking on form, monitoring speed of lifting, and checking heart rate 
and blood pressure at regular intervals.  Each exercise station is fit to the participant and the settings are 
recorded for future sessions.  All participants are provided both written and oral instructions on the use 
of the equipment.  Proper breathing techniques will be taught to all subjects in order to eliminate the 
potential of the valsalva maneuver which presents the greatest risk for cardiorespiratory response.  To 
minimize the possibility of injury, all lifts are conducted on weight machines which optimize the 
biomechanical aspects of the lifts and alleviate any danger of dropping weights.  All trainers hold current 
certifications in first aid and CPR. 
When subjects are enrolled in the physical activity intervention, all subjects will be informed of the 
potential risks due to the strain of exercise, and informed of procedures to alert researchers that they 
are indeed undergoing unnatural or worrisome strain.  Researchers will also periodically check the 
subject’s status during exercise to help minimize risk of exercise related responses.  Subjects will be 
informed that they are free to stop exercising at any time.  If a subject experiences any pain then the 
task will be discontinued for that subject until a further time if/when the subject would like to attempt 
the activity again.  If pain persists, the subject will not be asked to complete any further trials for the 
study.   
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To address the risk of uneasiness that some subjects may experience over the questionnaires, 
subjects will be invited to ask questions about the purpose of each questionnaire at the first test 
session.  They will also be told that if they feel they cannot complete a portion of a questionnaire that 
they will not be precluded from participation in the program.  
11. Describe how you will address privacy and/or confidentiality. 
All information gathered in this study will be treated and handled confidentially. All subject files that 
contain confidential information will be devoid of names or otherwise identifying features, and instead 
will include only a subject number (e.g. S01, S02, etc).  The master list of subject names and identifying 
numbers will be kept in a locked cabinet).    
12. If your research involves the use of schools (pre-kindergarten to university level) or other 
organizations (e.g., community clubs, companies), please attach a clearance letter from an 
administrator from your research site indicating that you have been given permission to conduct 
this research. For pre-kindergarten to grade 12 level schools, an administrator (e.g. principal or 
higher) should issue the permission. For post-secondary level schools the class instructor may 
grant permission. For Western Washington University, this requirement of a clearance letter is 
waived if you are recruiting subjects from a scheduled class. If you are recruiting subjects from a 
campus group (not a class) at Western Washington University, you are required to obtain a 
clearance letter from a leader or coordinator of the group. 
 N/A 
13. If your research involves the use of schools (pre-kindergarten to university level) or other 
organizations (e.g., community clubs, companies), and you plan to take still or video pictures as 
part of your research, please complete a) to d) below: 
 N/A 
a. Who have you contacted at the school district or organization involved, to determine the 
policy on the use of photography in the school or organization? 
b. Explain how your research plan conforms to the policy on the use of photography in the 
school or organization. 
c. Attach a copy of the school district or organization policy on the use of photography at the 
schools or organization. 
d. Explain how you will ensure that the only people recorded in your pictures will be the 
ones that have signed a consent form. 
In addition, please attach the following information: 
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1. A bibliography relevant to the subject matter of the proposed research. 
 Please see attached 
2. A copy of the informed consent form (a checklist is attached for you to use as a guide). 
 Please see attached. 
3. A current curriculum vitae. 
 Please see attached. 
4. A copy of the Certificate of Completion for Human Subjects Training from the online human 
subjects training module, for each person involved in the research who will have any contact with 
the subjects or their data.  (See “Training” at http://www.wwu.edu/depts/rsp/human.html) 
Human subject certification is valid for five years. 
 Please see attached. 
5. If your subjects are required to turn in a physician clearance form prior to participation, include a 
copy of the blank form. 












PHYSICAL ACTIVITY FOR PERSONS WITH DIABETES 
Physician's Clearance to Participate in a Physical Activity Program 
 
To the physician: Please read the Program Description that describes the procedures for this 
program. It is necessary to have this form completed before the participant can enroll in this 
physical activity program.   
 
Participant's name: 
   
 
Have you read the Consent Form  that describes the training and testing that will take place in 
this program? 
 
 YES          NO  Please request a copy before signing this clearance form.  
 

















___ Yes, it is my medical judgment that the above patient may participate in a weight 
 training and/or cardiovascular program. 
 
___ Yes, it is my medical judgment that the above patient may participate in a weight 






___ No, it is my medical judgment that the patient should not participate in a weight 




_____________________________             ___________________      _____________ 









Individual subject characteristics – A: 











- Pre (cm) 
Waist 
Circumference 
- Post (kg) 
S1 Control 66 182.00 115.00 117.50 118.50 121.00 
S2 Control 62 166.00 118.00 117.50 121.00 117.00 
S3 Control 37 169.00 130.00 133.00 140.00 134.00 
S4 Control 65 164.00 67.50 66.96 87.00 99.06 
S9 Control 76 162.00 82.00 82.50 108.50 106.00 
S10 Control 57 177.00 100.50 101.00 109.50 104.50 
S11 Control 59 170.00 96.50 87.50 109.00 104.00 
S13 Control 73 161.50 61.00 61.50 78.00 77.00 
S14 Control 53 147.00 90.00 90.00 112.50 119.50 
S15 Control 44 167.50 86.00 86.00 104.00 98.50 
S16 Control 76 167.00 104.00 104.50 125.00 118.00 
S17 Control 66 160.50 73.00 68.25 88.50 80.50 
S18 Control 56 161.00 110.50 104.25 116.00 101.50 
S19 Control 57 162.50 87.00 89.75 107.50 106.50 
S20 Control 78 177.50 103.50 102.00 116.50 109.50 
S21 Control 71 161.00 77.00 76.75 104.50 100.00 
S26 Control 63 171.50 90.00 91.00 105.50 100.50 
S5 Treatment 81 157.00 60.00 58.00 85.50 90.00 
S6 Treatment 63 162.00 82.50 82.50 101.00 94.00 
S7 Treatment 66 161.00 106.00 111.50 122.00 142.50 
S23 Treatment 52 166.00 102.50 99.32 123.00 115.00 
S27 Treatment 60 153.50 96.50 107.00 149.00 147.50 
S28 Treatment 53 184.00 95.00 94.50 100.50 94.50 
S29 Treatment  N 178.00 165.18 158.90 165.00 157.00 
S31 Treatment 61 185.00 119.50 117.00 124.50 117.00 
S32 Treatment 43 157.50 65.00 66.00 86.00 78.00 
S33 Treatment 60 170.50 88.00 91.00 99.00 97.50 
S34 Treatment 51 157.50 114.00 112.00 138.00 130.50 
S36 Treatment 61 170.00 73.50 74.50 101.00 90.00 
S37 Treatment 69 162.00 59.00 65.50 99.50 91.00 
S42 Treatment 84 160.50 69.50 69.00 99.00 95.00 
S44 Treatment 66 164.00 67.00 69.00 97.00 89.00 
S45 Treatment 58 170.00 128.00 127.50 137.00 136.50 
S47 Treatment 43 165.50 99.50 101.25 122.00 109.00 









- Pre (kg) 
Hip 
Circumference 















S1 Control 119.00 117.00 34.72 35.47 1.00 1.03 
S2 Control 141.50 131.00 42.82 42.38 0.86 0.89 
S3 Control 153.00 146.00 45.52 46.57 0.92 0.92 
S4 Control 97.50 96.52 25.10 25.05 0.89 1.03 
S9 Control 106.00 103.00 31.25 31.24 1.02 1.03 
S10 Control 109.50 107.00 32.08 32.24 1.00 0.98 
S11 Control 110.00 107.00 33.39 30.64 0.99 0.97 
S13 Control 95.00 93.50 23.39 23.43 0.82 0.82 
S14 Control 127.00 125.00 41.65 42.22 0.89 0.96 
S15 Control 113.00 106.00 30.65 30.47 0.92 0.93 
S16 Control 124.50 121.50 37.29 37.92 1.00 0.97 
S17 Control 103.00 94.50 28.34 26.83 0.86 0.85 
S18 Control 126.50 116.50 42.63 40.22 0.92 0.87 
S19 Control 110.00 104.50 32.95 33.99 0.98 1.02 
S20 Control 119.50 111.50 32.85 32.56 0.97 0.98 
S21 Control 106.50 103.00 29.71 29.61 0.98 0.97 
S26 Control 110.00 109.50 30.60 30.94 0.96 0.92 
S5 Treatment 102.00 96.00 24.34 23.53 0.84 0.94 
S6 Treatment 113.50 105.50 31.44 31.63 0.89 0.89 
S7 Treatment 134.00 137.50 40.89 43.02 0.91 1.04 
S23 Treatment 128.50 121.00 37.20 36.48 0.96 0.95 
S27 Treatment 147.00 139.50 40.96 45.71 1.01 1.06 
S28 Treatment 105.50 103.50 28.06 27.91 0.95 0.91 
S29 Treatment 160.00 142.50 52.13 49.87 1.03 1.10 
S31 Treatment 121.50 117.00 34.92 34.37 1.02 1.00 
S32 Treatment 101.50 100.50 26.20 26.44 0.85 0.78 
S33 Treatment 104.50 104.50 30.27 31.12 0.95 0.93 
S34 Treatment 139.50 133.00 45.96 44.86 0.99 0.98 
S36 Treatment 102.00 100.00 25.43 26.24 0.99 0.90 
S37 Treatment 98.00 96.00 22.48 24.96 1.02 0.95 
S42 Treatment 100.00 95.00 26.98 26.13 0.99 1.00 
S44 Treatment 98.00 96.00 24.91 25.81 0.99 0.93 
S45 Treatment 137.00 133.50 44.29 44.64 1.00 1.02 
S47 Treatment 127.00 115.00 36.33 37.19 0.96 0.95 
S48 Treatment 111.00 103.50 27.35 27.48 0.91 0.93 
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S1 Control 39.30 36.00 68.86 74.16 44.54 41.73 
S2 Control 51.70 49.90 56.47 58.42 60.55 58.42 
S3 Control 54.70 54.00 58.47 61.33 70.62 72.03 
S4 Control 29.70 30.80 47.26 46.58 20.00 16.24 
S9 Control 37.20 36.10 50.48 51.39 29.89 29.03 
S10 Control 28.80 27.00 70.22 72.44 28.35 26.81 
S11 Control 34.30 34.10 62.69 64.05 32.84 33.11 
S13 Control 26.70 26.10 43.77 44.81 14.74 15.83 
S14 Control 59.50 60.60 35.65 35.20 53.25 54.20 
S15 Control 38.00 37.50 53.02 53.12 32.43 31.89 
S16 Control 53.90 51.80 47.63 49.76 55.66 53.39 
S17 Control 49.00 46.70 36.83 35.65 35.33 31.25 
S18 Control 48.70 44.70 56.25 57.02 53.52 46.04 
S19 Control 35.80 36.90 55.20 55.84 30.75 32.66 
S20 Control 39.20 37.00 61.60 63.19 39.69 37.06 
S21 Control 45.70 43.60 41.14 42.77 34.61 33.11 
S26 Control 29.10 29.10 61.78 62.73 25.31 25.85 
S5 Treatment 44.50 42.40 34.11 33.07 26.44 24.36 
S6 Treatment 51.50 50.90 39.10 40.01 41.55 41.50 
S7 Treatment 56.50 56.40 45.50 46.86 59.42 60.60 
S23 Treatment 48.90 47.40 51.71 51.07 49.44 45.99 
S27 Treatment 51.80 50.90 51.26 52.16 55.02 54.02 
S28 Treatment 21.70 24.20 73.03 70.08 20.28 22.41 
S29 Treatment 57.20 57.30 70.94 69.54 94.94 93.17 
S31 Treatment 38.40 35.40 72.53 74.16 45.27 40.60 
S32 Treatment 36.00 35.10 41.50 42.23 23.31 22.82 
S33 Treatment 30.80 29.90 60.24 62.69 26.81 26.72 
S34 Treatment 52.90 54.80 52.62 50.03 59.42 60.69 
S36 Treatment 29.90 32.00 50.62 48.67 21.59 22.91 
S37 Treatment 36.40 33.90 40.37 42.27 23.04 21.68 
S42 Treatment 22.90 23.40 51.71 51.62 15.33 15.79 
S44 Treatment 27.00 28.90 48.17 47.90 17.78 19.50 
S45 Treatment 44.00 38.90 70.49 76.57 55.34 48.67 
S47 Treatment 40.70 41.50 58.69 58.33 40.28 41.41 
S48 Treatment 40.00 37.80 43.41 44.27 28.89 26.90 
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1 220 350 100 114 133 173 133 213 
2 95 220 30 47 30 87 25 53 
3 173 293 36 53 80 120 53 100 
4 170 213 24 40 53 80 50 53 
9 93 187 40 60 47 107 40 67 
10 147 267 74 113 107 160 107 167 
11 204 373 72 133 96 173 108 213 
13 207 267 45 60 84 107 60 93 
14 120 240 35 41 64 116 27 84 
15 173 275 53 54 80 114 80 87 
16 95 200 38 40 70 80 18 27 
17 133 240 36 47 53 90 36 80 
18 60 240 20 70 45 80 35 65 
19 233 360 60 53 113 153 120 173 
20 187 307 67 106 133 167 100 160 
21 133 247 33 37 67 100 47 73 
25 330 370 75 85 125 145 90 110 






























1 160 213 160 213 160 213 
2 30 73 30 73 30 73 
3 93 133 93 133 93 133 
4 45 67 45 67 45 67 
9 53 80 53 80 53 80 
10 80 120 80 120 80 120 
11 48 233 48 233 48 233 
13 67 107 67 107 67 107 
14 73 93 73 115 73 115 
15 107 147 107 147 107 147 
16 60 67 60 67 60 67 
17 27 93 40 93 40 93 
18 20 70 50 70 50 70 
19 67 133 67 173 67 173 
20 133 173 133 173 133 173 
21 60 67 60 67 60 67 
25 63 80 63 80 63 80 
















- Pre (kg) 
L Hip 
Abduction 
- Post (kg) 
R Hip 
Adduction 
- Post (kg) 
R Hip 
Adduction 
- Post (kg) 
1 160 213 160 213 160 213 
2 55 73 55 73 60 73 
3 93 133 93 133 93 133 
4 40 67 40 67 40 67 
9 40 80 40 80 53 80 
10 80 120 74 120 80 120 
11 48 233 48 233 48 217 
13 67 87 67 87 67 107 
14 68 115 68 115 73 115 
15 107 147 107 147 107 147 
16 45 67 45 67 60 67 
17 27 73 27 73 40 73 
18 20 70 20 70 20 70 
19 67 107 67 107 67 133 
20 133 173 133 173 133 173 
21 60 67 60 67 60 67 
25 45 80 45 80 45 80 









- Pre (kg) 
L Hip 
Adduction 
- Post (kg) 
Tricep 
Extension 





1 160 213 107 127 
2 60 73 30 60 
3 93 133 40 93 
4 40 67 35 40 
9 53 80 33 73 
10 80 120 60 113 
11 48 217 74 140 
13 67 107 44 60 
14 73 115 37 60 
15 107 147 53 67 
16 60 67 38 33 
17 40 73 27 37 
18 20 70 30 70 
19 67 133 73 113 
20 133 173 72 107 
21 60 67 47 60 
25 45 80 80 95 








- Pre (kg) 
Plantarflexion 
- Post (kg) 
Dorsiflexion 
- Pre (kg) 
Dorsiflexion 
- Post (kg) 
1 120 133 93 133 
2 110 173 35 83 
3 147 227 82 120 
4 60 173 60 40 
9 67 140 60 40 
10 107 200 73 100 
11 108 267 30 60 
13 133 227 40 80 
14 130 240 50 82 
15 160 253 67 120 
16 80 147 30 53 
17 93 213 27 47 
18 60 170 30 80 
19 120 253 67 53 
20 160 293 80 140 
21 153 227 40 84 
25 200 230 70 90 
















Effect Value F 
Hypothesis 















































 1 33 0.473 0.016 
  
 
a. Exact statistic 
b. Design: Intercept + group  



















15.14 1 15.14 10.498 0.003 0.241 
Greenhouse-
Geisser 
15.14 1 15.14 10.498 0.003 0.241 
Huynh-Feldt 15.14 1 15.14 10.498 0.003 0.241 





0.759 1 0.759 0.526 0.473 0.016 
Greenhouse-
Geisser 
0.759 1 0.759 0.526 0.473 0.016 
Huynh-Feldt 0.759 1 0.759 0.526 0.473 0.016 
Lower-bound 0.759 1 0.759 0.526 0.473 0.016 
Error(time) Sphericity 
Assumed 
47.595 33 1.442 
      
Greenhouse-
Geisser 
47.595 33 1.442 
      
Huynh-Feldt 47.595 33 1.442 
      
Lower-bound 47.595 33 1.442 
      
                
 
 












Intercept 115023.5 1 115023.5 524.272 0 0.941 
group 1.194 1 1.194 0.005 0.942 0 
Error 7240.094 33 219.397       










Effect Value F 
Hypothesis 















































 1 33 0.084 0.088 
                
 
a. Exact statistic 
b. Design: Intercept + group  


















70 1 70 7.206 0.011 0.179 
Greenhouse-
Geisser 
70 1 70 7.206 0.011 0.179 
Huynh-Feldt 70 1 70 7.206 0.011 0.179 





30.865 1 30.865 3.177 0.084 0.088 
Greenhouse-
Geisser 
30.865 1 30.865 3.177 0.084 0.088 
Huynh-Feldt 30.865 1 30.865 3.177 0.084 0.088 
Lower-bound 30.865 1 30.865 3.177 0.084 0.088 
Error(time) Sphericity 
Assumed 
320.576 33 9.714 
      
Greenhouse-
Geisser 
320.576 33 9.714 
      
Huynh-Feldt 320.576 33 9.714 
      
Lower-bound 320.576 33 9.714 
      
                
 
 










Intercept 975256.3 1 975256.3 750.699 0 0.958 
group 30.291 1 30.291 0.023 0.88 0.001 
Error 42871.31 33 1299.13       











Effect Value F 
Hypothesis 















































 1 33 0.632 0.007 
                


















83.803 1 83.803 6.273 0.017 0.16 
Greenhouse-
Geisser 
83.803 1 83.803 6.273 0.017 0.16 
Huynh-Feldt 83.803 1 83.803 6.273 0.017 0.16 





3.122 1 3.122 0.234 0.632 0.007 
Greenhouse-
Geisser 
3.122 1 3.122 0.234 0.632 0.007 
Huynh-Feldt 3.122 1 3.122 0.234 0.632 0.007 
Lower-bound 3.122 1 3.122 0.234 0.632 0.007 
Error(test) Sphericity 
Assumed 
440.889 33 13.36 
      
Greenhouse-
Geisser 
440.889 33 13.36 
      
Huynh-Feldt 440.889 33 13.36 
      
Lower-bound 440.889 33 13.36 
      
                
 












Intercept 505805.5 1 505805.5 163.563 0 0.832 
group 7.24 1 7.24 0.002 0.962 0 
Error 102049.7 33 3092.414       








Tests of Within-Subjects Effects 
Measure: Weight 
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
time Sphericity Assumed 8.417 1 8.417 .121 .731 
Greenhouse-Geisser 8.417 1.000 8.417 .121 .731 
Huynh-Feldt 8.417 1.000 8.417 .121 .731 
Lower-bound 8.417 1.000 8.417 .121 .731 
time * Group Sphericity Assumed 32.933 1 32.933 .472 .497 
Greenhouse-Geisser 32.933 1.000 32.933 .472 .497 
Huynh-Feldt 32.933 1.000 32.933 .472 .497 
Lower-bound 32.933 1.000 32.933 .472 .497 
Error(test) Sphericity Assumed 2302.860 33 69.784   
Greenhouse-Geisser 2302.860 33.000 69.784   
Huynh-Feldt 2302.860 33.000 69.784   















time Sphericity Assumed .004 .121 .063 
Greenhouse-Geisser .004 .121 .063 
Huynh-Feldt .004 .121 .063 
Lower-bound .004 .121 .063 
time * Group Sphericity Assumed .014 .472 .102 
Greenhouse-Geisser .014 .472 .102 
Huynh-Feldt .014 .472 .102 
Lower-bound .014 .472 .102 
a. Computed using alpha = .05 




Type III Sum of 
Squares df Mean Square F Sig. 
Partial Eta 
Squared 
Intercept 601285.946 1 601285.946 614.256 .000 .949 
Group 21.882 1 21.882 .022 .882 .001 







Tests of Within-Subjects Effects 
Measure: WaistCircumference 
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
time Sphericity Assumed 255.613 1 255.613 11.021 .002 
Greenhouse-Geisser 255.613 1.000 255.613 11.021 .002 
Huynh-Feldt 255.613 1.000 255.613 11.021 .002 
Lower-bound 255.613 1.000 255.613 11.021 .002 
time * Group Sphericity Assumed 6.744 1 6.744 .291 .593 
Greenhouse-Geisser 6.744 1.000 6.744 .291 .593 
Huynh-Feldt 6.744 1.000 6.744 .291 .593 
Lower-bound 6.744 1.000 6.744 .291 .593 
Error(test) Sphericity Assumed 765.401 33 23.194   
Greenhouse-Geisser 765.401 33.000 23.194   
Huynh-Feldt 765.401 33.000 23.194   














time Sphericity Assumed .250 11.021 .896 
Greenhouse-Geisser .250 11.021 .896 
Huynh-Feldt .250 11.021 .896 
Lower-bound .250 11.021 .896 
time * Group Sphericity Assumed .009 .291 .082 
Greenhouse-Geisser .009 .291 .082 
Huynh-Feldt .009 .291 .082 
Lower-bound .009 .291 .082 
a. Computed using alpha = .05 




Type III Sum of 
Squares df Mean Square F Sig. 
Partial Eta 
Squared 
Intercept 838670.887 1 838670.887 1157.692 .000 .972 
Group 336.044 1 336.044 .464 .501 .014 





Tests of Within-Subjects Effects 
Measure: HipCircumference 
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
time Sphericity Assumed 408.939 1 408.939 48.425 .000 
Greenhouse-Geisser 408.939 1.000 408.939 48.425 .000 
Huynh-Feldt 408.939 1.000 408.939 48.425 .000 
Lower-bound 408.939 1.000 408.939 48.425 .000 
time * Group Sphericity Assumed .843 1 .843 .100 .754 
Greenhouse-Geisser .843 1.000 .843 .100 .754 
Huynh-Feldt .843 1.000 .843 .100 .754 
Lower-bound .843 1.000 .843 .100 .754 
Error(test) Sphericity Assumed 278.677 33 8.445   
Greenhouse-Geisser 278.677 33.000 8.445   
Huynh-Feldt 278.677 33.000 8.445   














time Sphericity Assumed .595 48.425 1.000 
Greenhouse-Geisser .595 48.425 1.000 
Huynh-Feldt .595 48.425 1.000 
Lower-bound .595 48.425 1.000 
time * Group Sphericity Assumed .003 .100 .061 
Greenhouse-Geisser .003 .100 .061 
Huynh-Feldt .003 .100 .061 
Lower-bound .003 .100 .061 
a. Computed using alpha = .05 




Type III Sum of 
Squares df Mean Square F Sig. 
Partial Eta 
Squared 
Intercept 920942.321 1 920942.321 1738.390 .000 .981 
Group 82.413 1 82.413 .156 .696 .005 







Tests of Within-Subjects Effects 
Measure: BMI 
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
time Sphericity Assumed 91642.585 1 91642.585 191.539 .000 
Greenhouse-Geisser 91642.585 1.000 91642.585 191.539 .000 
Huynh-Feldt 91642.585 1.000 91642.585 191.539 .000 
Lower-bound 91642.585 1.000 91642.585 191.539 .000 
time * Group Sphericity Assumed 4.612 1 4.612 .010 .922 
Greenhouse-Geisser 4.612 1.000 4.612 .010 .922 
Huynh-Feldt 4.612 1.000 4.612 .010 .922 
Lower-bound 4.612 1.000 4.612 .010 .922 
Error(test) Sphericity Assumed 15788.970 33 478.454   
Greenhouse-Geisser 15788.970 33.000 478.454   
Huynh-Feldt 15788.970 33.000 478.454   














time Sphericity Assumed .853 191.539 1.000 
Greenhouse-Geisser .853 191.539 1.000 
Huynh-Feldt .853 191.539 1.000 
Lower-bound .853 191.539 1.000 
time * Group Sphericity Assumed .000 .010 .051 
Greenhouse-Geisser .000 .010 .051 
Huynh-Feldt .000 .010 .051 
Lower-bound .000 .010 .051 
a. Computed using alpha = .05 




Type III Sum of 
Squares df Mean Square F Sig. 
Partial Eta 
Squared 
Intercept 340540.106 1 340540.106 1649.103 .000 .980 
Group 17.200 1 17.200 .083 .775 .003 








Tests of Within-Subjects Effects 
Measure: WHR 
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
time Sphericity Assumed 6.450 1 6.450 549.284 .000 
Greenhouse-Geisser 6.450 1.000 6.450 549.284 .000 
Huynh-Feldt 6.450 1.000 6.450 549.284 .000 
Lower-bound 6.450 1.000 6.450 549.284 .000 
time * Group Sphericity Assumed 5.104E-6 1 5.104E-6 .000 .983 
Greenhouse-Geisser 5.104E-6 1.000 5.104E-6 .000 .983 
Huynh-Feldt 5.104E-6 1.000 5.104E-6 .000 .983 
Lower-bound 5.104E-6 1.000 5.104E-6 .000 .983 
Error(test) Sphericity Assumed .388 33 .012   
Greenhouse-Geisser .388 33.000 .012   
Huynh-Feldt .388 33.000 .012   
















time Sphericity Assumed .943 549.284 1.000 
Greenhouse-Geisser .943 549.284 1.000 
Huynh-Feldt .943 549.284 1.000 
Lower-bound .943 549.284 1.000 
time * Group Sphericity Assumed .000 .000 .050 
Greenhouse-Geisser .000 .000 .050 
Huynh-Feldt .000 .000 .050 
Lower-bound .000 .000 .050 
a. Computed using alpha = .05 




Type III Sum of 
Squares df Mean Square F Sig. 
Partial Eta 
Squared 
Intercept 29.562 1 29.562 1735.718 .000 .981 
Group .014 1 .014 .801 .377 .024 







Tests of Within-Subjects Effects 
Measure: LegPress 
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
time Sphericity Assumed 100912.111 1 100912.111 122.319 .000 
Greenhouse-Geisser 100912.111 1.000 100912.111 122.319 .000 
Huynh-Feldt 100912.111 1.000 100912.111 122.319 .000 
Lower-bound 100912.111 1.000 100912.111 122.319 .000 
Error(time) Sphericity Assumed 14024.889 17 824.993   
Greenhouse-Geisser 14024.889 17.000 824.993   
Huynh-Feldt 14024.889 17.000 824.993   











time Sphericity Assumed .878 122.319 
Greenhouse-Geisser .878 122.319 
Huynh-Feldt .878 122.319 
Lower-bound .878 122.319 








Tests of Within-Subjects Effects 
Measure: BicepCurl 
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
time Sphericity Assumed 3025.000 1 3025.000 18.976 .000 
Greenhouse-Geisser 3025.000 1.000 3025.000 18.976 .000 
Huynh-Feldt 3025.000 1.000 3025.000 18.976 .000 
Lower-bound 3025.000 1.000 3025.000 18.976 .000 
Error(time) Sphericity Assumed 2710.000 17 159.412   
Greenhouse-Geisser 2710.000 17.000 159.412   
Huynh-Feldt 2710.000 17.000 159.412   
Lower-bound 2710.000 17.000 159.412   
 
 









time Sphericity Assumed .527 18.976 .984 
Greenhouse-Geisser .527 18.976 .984 
Huynh-Feldt .527 18.976 .984 
Lower-bound .527 18.976 .984 






Tests of Within-Subjects Effects 
Measure: DeltRaise 
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
time Sphericity Assumed 11808.444 1 11808.444 52.639 .000 
Greenhouse-Geisser 11808.444 1.000 11808.444 52.639 .000 
Huynh-Feldt 11808.444 1.000 11808.444 52.639 .000 
Lower-bound 11808.444 1.000 11808.444 52.639 .000 
Error(time) Sphericity Assumed 3813.556 17 224.327   
Greenhouse-Geisser 3813.556 17.000 224.327   
Huynh-Feldt 3813.556 17.000 224.327   













time Sphericity Assumed .756 52.639 1.000 
Greenhouse-Geisser .756 52.639 1.000 
Huynh-Feldt .756 52.639 1.000 
Lower-bound .756 52.639 1.000 






Tests of Within-Subjects Effects 
Measure: ChestPress 
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
time Sphericity Assumed 13963.361 1 13963.361 39.503 .000 
Greenhouse-Geisser 13963.361 1.000 13963.361 39.503 .000 
Huynh-Feldt 13963.361 1.000 13963.361 39.503 .000 
Lower-bound 13963.361 1.000 13963.361 39.503 .000 
Error(time) Sphericity Assumed 6009.139 17 353.479   
Greenhouse-Geisser 6009.139 17.000 353.479   
Huynh-Feldt 6009.139 17.000 353.479   













time Sphericity Assumed .699 39.503 1.000 
Greenhouse-Geisser .699 39.503 1.000 
Huynh-Feldt .699 39.503 1.000 
Lower-bound .699 39.503 1.000 





R Hip Flexion 
Tests of Within-Subjects Effects 
Measure:RHipFlex 
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
time Sphericity Assumed 16598.028 1 16598.028 20.902 .000 
Greenhouse-Geisser 16598.028 1.000 16598.028 20.902 .000 
Huynh-Feldt 16598.028 1.000 16598.028 20.902 .000 
Lower-bound 16598.028 1.000 16598.028 20.902 .000 
Error(time) Sphericity Assumed 13499.472 17 794.087   
Greenhouse-Geisser 13499.472 17.000 794.087   
Huynh-Feldt 13499.472 17.000 794.087   













time Sphericity Assumed .551 20.902 .990 
Greenhouse-Geisser .551 20.902 .990 
Huynh-Feldt .551 20.902 .990 
Lower-bound .551 20.902 .990 





L Hip Flexion 
Tests of Within-Subjects Effects 
Measure: LHipFlex 
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
time Sphericity Assumed 16684.028 1 16684.028 21.442 .000 
Greenhouse-Geisser 16684.028 1.000 16684.028 21.442 .000 
Huynh-Feldt 16684.028 1.000 16684.028 21.442 .000 
Lower-bound 16684.028 1.000 16684.028 21.442 .000 
Error(time) Sphericity Assumed 13227.472 17 778.087   
Greenhouse-Geisser 13227.472 17.000 778.087   
Huynh-Feldt 13227.472 17.000 778.087   













time Sphericity Assumed .558 21.442 .992 
Greenhouse-Geisser .558 21.442 .992 
Huynh-Feldt .558 21.442 .992 
Lower-bound .558 21.442 .992 






R Hip Extension 
Tests of Within-Subjects Effects 
Measure: RHipExt 
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
time Sphericity Assumed 17424.000 1 17424.000 19.784 .000 
Greenhouse-Geisser 17424.000 1.000 17424.000 19.784 .000 
Huynh-Feldt 17424.000 1.000 17424.000 19.784 .000 
Lower-bound 17424.000 1.000 17424.000 19.784 .000 
Error(time) Sphericity Assumed 14972.000 17 880.706   
Greenhouse-Geisser 14972.000 17.000 880.706   
Huynh-Feldt 14972.000 17.000 880.706   













time Sphericity Assumed .538 19.784 .987 
Greenhouse-Geisser .538 19.784 .987 
Huynh-Feldt .538 19.784 .987 
Lower-bound .538 19.784 .987 





L Hip Extension 
Tests of Within-Subjects Effects 
Measure: LHipExt 
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
time Sphericity Assumed 17424.000 1 17424.000 19.784 .000 
Greenhouse-Geisser 17424.000 1.000 17424.000 19.784 .000 
Huynh-Feldt 17424.000 1.000 17424.000 19.784 .000 
Lower-bound 17424.000 1.000 17424.000 19.784 .000 
Error(time) Sphericity Assumed 14972.000 17 880.706   
Greenhouse-Geisser 14972.000 17.000 880.706   
Huynh-Feldt 14972.000 17.000 880.706   













time Sphericity Assumed .538 19.784 .987 
Greenhouse-Geisser .538 19.784 .987 
Huynh-Feldt .538 19.784 .987 
Lower-bound .538 19.784 .987 





R Hip Abduction 
Tests of Within-Subjects Effects 
Measure: RHipAbd 
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
time Sphericity Assumed 16684.028 1 16684.028 23.708 .000 
Greenhouse-Geisser 16684.028 1.000 16684.028 23.708 .000 
Huynh-Feldt 16684.028 1.000 16684.028 23.708 .000 
Lower-bound 16684.028 1.000 16684.028 23.708 .000 
Error(time) Sphericity Assumed 11963.472 17 703.734   
Greenhouse-Geisser 11963.472 17.000 703.734   
Huynh-Feldt 11963.472 17.000 703.734   













time Sphericity Assumed .582 23.708 .996 
Greenhouse-Geisser .582 23.708 .996 
Huynh-Feldt .582 23.708 .996 
Lower-bound .582 23.708 .996 





L Hip Abduction 
Tests of Within-Subjects Effects 
Measure: LHipAbd 
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
time Sphericity Assumed 16943.361 1 16943.361 24.079 .000 
Greenhouse-Geisser 16943.361 1.000 16943.361 24.079 .000 
Huynh-Feldt 16943.361 1.000 16943.361 24.079 .000 
Lower-bound 16943.361 1.000 16943.361 24.079 .000 
Error(time) Sphericity Assumed 11962.139 17 703.655   
Greenhouse-Geisser 11962.139 17.000 703.655   
Huynh-Feldt 11962.139 17.000 703.655   













time Sphericity Assumed .586 24.079 .996 
Greenhouse-Geisser .586 24.079 .996 
Huynh-Feldt .586 24.079 .996 
Lower-bound .586 24.079 .996 





R Hip Adduction 
Tests of Within-Subjects Effects 
Measure: RHipAdd 
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
time Sphericity Assumed 15792.111 1 15792.111 25.484 .000 
Greenhouse-Geisser 15792.111 1.000 15792.111 25.484 .000 
Huynh-Feldt 15792.111 1.000 15792.111 25.484 .000 
Lower-bound 15792.111 1.000 15792.111 25.484 .000 
Error(time) Sphericity Assumed 10534.889 17 619.699   
Greenhouse-Geisser 10534.889 17.000 619.699   
Huynh-Feldt 10534.889 17.000 619.699   













time Sphericity Assumed .600 25.484 .997 
Greenhouse-Geisser .600 25.484 .997 
Huynh-Feldt .600 25.484 .997 
Lower-bound .600 25.484 .997 





L Hip Adduction 
Tests of Within-Subjects Effects 
Measure: LHipAdd 
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
time Sphericity Assumed 15792.111 1 15792.111 25.484 .000 
Greenhouse-Geisser 15792.111 1.000 15792.111 25.484 .000 
Huynh-Feldt 15792.111 1.000 15792.111 25.484 .000 
Lower-bound 15792.111 1.000 15792.111 25.484 .000 
Error(time) Sphericity Assumed 10534.889 17 619.699   
Greenhouse-Geisser 10534.889 17.000 619.699   
Huynh-Feldt 10534.889 17.000 619.699   
Lower-bound 10534.889 17.000 619.699   
 
 









time Sphericity Assumed .600 25.484 .997 
Greenhouse-Geisser .600 25.484 .997 
Huynh-Feldt .600 25.484 .997 
Lower-bound .600 25.484 .997 






Tests of Within-Subjects Effects 
Measure: TriExt 
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
time Sphericity Assumed 6346.778 1 6346.778 34.635 .000 
Greenhouse-Geisser 6346.778 1.000 6346.778 34.635 .000 
Huynh-Feldt 6346.778 1.000 6346.778 34.635 .000 
Lower-bound 6346.778 1.000 6346.778 34.635 .000 
Error(time) Sphericity Assumed 3115.222 17 183.248   
Greenhouse-Geisser 3115.222 17.000 183.248   
Huynh-Feldt 3115.222 17.000 183.248   
Lower-bound 3115.222 17.000 183.248   
 
 









time Sphericity Assumed .671 34.635 1.000 
Greenhouse-Geisser .671 34.635 1.000 
Huynh-Feldt .671 34.635 1.000 
Lower-bound .671 34.635 1.000 






Tests of Within-Subjects Effects 
Measure: PF 
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
time Sphericity Assumed 70933.444 1 70933.444 97.930 .000 
Greenhouse-Geisser 70933.444 1.000 70933.444 97.930 .000 
Huynh-Feldt 70933.444 1.000 70933.444 97.930 .000 
Lower-bound 70933.444 1.000 70933.444 97.930 .000 
Error(time) Sphericity Assumed 12313.556 17 724.327   
Greenhouse-Geisser 12313.556 17.000 724.327   
Huynh-Feldt 12313.556 17.000 724.327   
Lower-bound 12313.556 17.000 724.327   
 
 









time Sphericity Assumed .852 97.930 1.000 
Greenhouse-Geisser .852 97.930 1.000 
Huynh-Feldt .852 97.930 1.000 
Lower-bound .852 97.930 1.000 






Tests of Within-Subjects Effects 
Measure: DF 
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
time Sphericity Assumed 6696.694 1 6696.694 23.287 .000 
Greenhouse-Geisser 6696.694 1.000 6696.694 23.287 .000 
Huynh-Feldt 6696.694 1.000 6696.694 23.287 .000 
Lower-bound 6696.694 1.000 6696.694 23.287 .000 
Error(time) Sphericity Assumed 4888.806 17 287.577   
Greenhouse-Geisser 4888.806 17.000 287.577   
Huynh-Feldt 4888.806 17.000 287.577   
Lower-bound 4888.806 17.000 287.577   
 
 









time Sphericity Assumed .578 23.287 .995 
Greenhouse-Geisser .578 23.287 .995 
Huynh-Feldt .578 23.287 .995 
Lower-bound .578 23.287 .995 
a. Computed using alpha = .05 
 
